1
|
Tian B, Xu LL, Jiang LD, Lin X, Shen J, Shen H, Su KJ, Gong R, Qiu C, Luo Z, Yao JH, Wang ZQ, Xiao HM, Zhang LS, Deng HW. Identification of the serum metabolites associated with cow milk consumption in Chinese Peri-/Postmenopausal women. Int J Food Sci Nutr 2024:1-13. [PMID: 38918932 DOI: 10.1080/09637486.2024.2366223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Accepted: 05/30/2024] [Indexed: 06/27/2024]
Abstract
Cow milk consumption (CMC) and downstream alterations of serum metabolites are commonly considered important factors regulating human health status. Foods may lead to metabolic changes directly or indirectly through remodelling gut microbiota (GM). We sought to identify the metabolic alterations in Chinese Peri-/Postmenopausal women with habitual CMC and explore if the GM mediates the CMC-metabolite associations. 346 Chinese Peri-/Postmenopausal women participants were recruited in this study. Fixed effects regression and partial least squares discriminant analysis (PLS-DA) were applied to reveal alterations of serum metabolic features in different CMC groups. Spearman correlation coefficient was computed to detect metabolome-metagenome association. 36 CMC-associated metabolites including palmitic acid (FA(16:0)), 7alpha-hydroxy-4-cholesterin-3-one (7alphaC4), citrulline were identified by both fixed effects regression (FDR < 0.05) and PLS-DA (VIP score > 2). Some significant metabolite-GM associations were observed, including FA(16:0) with gut species Bacteroides ovatus, Bacteroides sp.D2. These findings would further prompt our understanding of the effect of cow milk on human health.
Collapse
Affiliation(s)
- Bo Tian
- Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China
| | - Lu-Lu Xu
- School of Physical Science and Engineering, College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China
| | - Lin-Dong Jiang
- Tulane Center for Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, LA, USA
| | - Xu Lin
- Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
- Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China
| | - Jie Shen
- Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
| | - Hui Shen
- Tulane Center for Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, LA, USA
| | - Kuan-Jui Su
- Tulane Center for Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, LA, USA
| | - Rui Gong
- Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China
- Department of Cadre Ward Endocrinology, Gansu Provincial Hospital, Lanzhou, China
| | - Chuan Qiu
- Tulane Center for Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, LA, USA
| | - Zhe Luo
- Tulane Center for Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, LA, USA
| | - Jia-Heng Yao
- School of Physical Science and Engineering, College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China
| | - Zhuo-Qi Wang
- School of Physical Science and Engineering, College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China
| | - Hong-Mei Xiao
- Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha, China
| | - Li-Shu Zhang
- School of Physical Science and Engineering, College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China
| | - Hong-Wen Deng
- Tulane Center for Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, LA, USA
| |
Collapse
|
2
|
Goswami S, Zhang Q, Celik CE, Reich EM, Yilmaz ÖH. Dietary fat and lipid metabolism in the tumor microenvironment. Biochim Biophys Acta Rev Cancer 2023; 1878:188984. [PMID: 37722512 PMCID: PMC10937091 DOI: 10.1016/j.bbcan.2023.188984] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 08/26/2023] [Accepted: 08/28/2023] [Indexed: 09/20/2023]
Abstract
Metabolic reprogramming has been considered a core hallmark of cancer, in which excessive accumulation of lipids promote cancer initiation, progression and metastasis. Lipid metabolism often includes the digestion and absorption of dietary fat, and the ways in which cancer cells utilize lipids are often influenced by the complex interactions within the tumor microenvironment. Among multiple cancer risk factors, obesity has a positive association with multiple cancer types, while diets like calorie restriction and fasting improve health and delay cancer. Impact of these diets on tumorigenesis or cancer prevention are generally studied on cancer cells, despite heterogeneity of the tumor microenvironment. Cancer cells regularly interact with these heterogeneous microenvironmental components, including immune and stromal cells, to promote cancer progression and metastasis, and there is an intricate metabolic crosstalk between these compartments. Here, we focus on discussing fat metabolism and response to dietary fat in the tumor microenvironment, focusing on both immune and stromal components and shedding light on therapeutic strategies surrounding lipid metabolic and signaling pathways.
Collapse
Affiliation(s)
- Swagata Goswami
- Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
| | - Qiming Zhang
- Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
| | - Cigdem Elif Celik
- Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Hacettepe Univ, Canc Inst, Department Basic Oncol, Ankara TR-06100, Turkiye
| | - Ethan M Reich
- Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - Ömer H Yilmaz
- Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pathology, Massachusetts General Hospital and Beth Israel Deaconness Medical Center and Harvard Medical School, Boston, MA 02114, USA.
| |
Collapse
|
3
|
Shafie F, Tajadod S, Aslany Z, Allahyari P, Vahdat M, Shekari S, Mohseni GK, Gholamalizadeh M, Mohammadi S, Bahar B, Shafaei H, Doaei S. Breast cancer and dietary fat quality indices in Iranian women: A case-control study. Front Oncol 2023; 12:993397. [PMID: 36741722 PMCID: PMC9895810 DOI: 10.3389/fonc.2022.993397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Accepted: 12/30/2022] [Indexed: 01/21/2023] Open
Abstract
Background The association between breast cancer (BC) and different indices of dietary fats has not been well-studied. Thus, this study aimed to investigate the association between BC and dietary fat quality (DFQ) indices in Iranian women. Methods This case-control study was conducted on 120 women with breast cancer and 240 healthy women in Tehran, Iran. Food Frequency Questionnaire and nutritionist IV software were used to assess the intake of dietary fats and to calculate the DFQ indices. Results The patients with BC had a higher total fat (TF) (P < 0.01) and a lower ratio of polyunsaturated fatty acids (PUFAs) omega-3 to PUFAs omega-6 (ω-3/ω-6) compared with the controls (P < 0.001). TF had a significant association with BC risk (OR: 1.16; 95% CI: 1.01-1.33, P < 0.001). No significant association was found between BC and PUFA/saturated fatty acid ratio or the ω-3/ω-6 ratio. Conclusion The patients with BC had a lower ω-3/ω-6 ratio and a higher total dietary fat intake than the healthy women. Total dietary fat intake was also directly associated with the risk of BC. Thus, low-fat diets may have beneficial effects for BC prevention. Further longitudinal studies are warranted.
Collapse
Affiliation(s)
- Fatemeh Shafie
- Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Shirin Tajadod
- Department of Nutrition, School Of Public Health, International Campus, Iran University of Medical Sciences, Tehran, Iran
| | - Zahra Aslany
- The Ohio State University Interdisciplinary ph.D. program in Nutrition (OSUN), Columbus, United States,The Ohio State University Comprehensive Cancer Center, Columbus, United States
| | - Pooneh Allahyari
- Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, Islamic Azad University, Central Tehran Branch, Tehran, Iran
| | - Mahsa Vahdat
- Aboozar Children’s Medical Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Soheila Shekari
- Department of Nutrition, Science and Research Branch, Islamic Azad University, Tehran, Iran
| | - Golsa Khalatbari Mohseni
- Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Maryam Gholamalizadeh
- Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Saeideh Mohammadi
- Department of Nutrition, Zanjan University of Medical Sciences, Zanjan, Iran
| | - Bojlul Bahar
- Nutrition Sciences and Applied Food Safety Studies, Research Centre for Global Development, School of Sport and Health Sciences, University of Central Lancashire, Preston, United Kingdom
| | - Hanieh Shafaei
- Nursing and Midwifery School, Guilan University of Medical Sciences, Rasht, Iran
| | - Saeid Doaei
- Department of Community Nutrition, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran,*Correspondence: Saeid Doaei,
| |
Collapse
|
4
|
Cohen SS, Bylsma LC, Movva N, Alexander DD. Theoretical attributable risk analysis and Disability Adjusted Life Years (DALYs) based on increased dairy consumption. BMC Public Health 2022; 22:1625. [PMID: 36030208 PMCID: PMC9420283 DOI: 10.1186/s12889-022-14042-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Accepted: 08/22/2022] [Indexed: 11/12/2022] Open
Abstract
Background Identification of modifiable risk factors that may impact chronic disease risk is critical to public health. Our study objective was to conduct a theoretical population attributable risk analysis to estimate the burden of disease from low dairy intake and to estimate the impact of increased dairy intake on United States (US)-based disability adjusted life years (DALYs). Methods We conducted a comprehensive literature review to identify statistically significant summary relative risk estimates (SRREs) from recent meta-analyses of dairy consumption and key chronic disease outcomes. The SRREs were applied to preventive fractions using a range of categories (low to high) for population consumption of dairy products. The preventive fraction estimates were then applied to the number of DALYs for each health outcome in the US based on 2019 WHO estimates. The population attributable risk proportion estimates were calculated using the inverse of the SRRE from each meta-analysis using the same range of categories of consumption. These values were subsequently applied to the DALYs estimates to estimate the theoretical burden of disease attributable to low dairy intake. Results Statistically significant SRREs were identified in recent meta-analyses of total dairy consumption in relation to breast cancer, colorectal cancer, cardiovascular disease (CVD), type 2 diabetes (T2D), stroke, and hypertension. In this theoretical analysis, nearly 850,000 DALYs (or 5.0% of estimated years of healthy life lost) due to CVD and 200,000 DALYs (4.5%) due to T2D may be prevented by increased dairy consumption. Approximately 100,000 DALYs due to breast cancer (7.5%) and approximately 120,000 DALYs (8.5%) due to colorectal cancer may be prevented by high dairy intake. The numbers of DALYs for stroke and hypertension that may be prevented by increased dairy consumption were approximately 210,000 (6.0%) and 74,000 (5.5%), respectively. Conclusions Consumption of dairy products has been associated with decreased risk of multiple chronic diseases of significant public health importance. The burden of disease that may potentially be prevented by increasing dairy consumption is substantial, and population-wide improvement in meeting recommended daily dairy intake goals could have a notable public health impact. However, this analysis is theoretical, and thus additional studies providing empirical evidence are needed to further clarify potential relationships between dairy intake and various health outcomes. Supplementary Information The online version contains supplementary material available at 10.1186/s12889-022-14042-7.
Collapse
Affiliation(s)
- Sarah S Cohen
- EpidStrategies, a division of ToxStrategies, Inc., 1249 Kildaire Farm Road #134, Cary, NC, 27511, USA.
| | - Lauren C Bylsma
- EpidStrategies, a division of ToxStrategies, Inc., 1249 Kildaire Farm Road #134, Cary, NC, 27511, USA
| | - Naimisha Movva
- EpidStrategies, a division of ToxStrategies, Inc., 1249 Kildaire Farm Road #134, Cary, NC, 27511, USA
| | | |
Collapse
|
5
|
Taylor SR, Falcone JN, Cantley LC, Goncalves MD. Developing dietary interventions as therapy for cancer. Nat Rev Cancer 2022; 22:452-466. [PMID: 35614234 DOI: 10.1038/s41568-022-00485-y] [Citation(s) in RCA: 55] [Impact Index Per Article: 27.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/29/2022] [Indexed: 12/11/2022]
Abstract
Cancer cells acquire distinct metabolic preferences based on their tissue of origin, genetic alterations and degree of interaction with systemic hormones and metabolites. These adaptations support the increased nutrient demand required for increased growth and proliferation. Diet is the major source of nutrients for tumours, yet dietary interventions lack robust evidence and are rarely prescribed by clinicians for the treatment of cancer. Well-controlled diet studies in patients with cancer are rare, and existing studies have been limited by nonspecific enrolment criteria that inappropriately grouped together subjects with disparate tumour and host metabolic profiles. This imprecision may have masked the efficacy of the intervention for appropriate candidates. Here, we review the metabolic alterations and key vulnerabilities that occur across multiple types of cancer. We describe how these vulnerabilities could potentially be targeted using dietary therapies including energy or macronutrient restriction and intermittent fasting regimens. We also discuss recent trials that highlight how dietary strategies may be combined with pharmacological therapies to treat some cancers, potentially ushering a path towards precision nutrition for cancer.
Collapse
Affiliation(s)
- Samuel R Taylor
- Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
- Weill Cornell/Rockefeller/Sloan Kettering Tri-I MD-PhD program, New York, NY, USA
| | - John N Falcone
- Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
| | - Lewis C Cantley
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
| | - Marcus D Goncalves
- Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
| |
Collapse
|
6
|
Wajszczyk B, Charzewska J, Godlewski D, Zemła B, Nowakowska E, Kozaczka M, Chilimoniuk M, Pathak DR. Consumption of Dairy Products and the Risk of Developing Breast Cancer in Polish Women. Nutrients 2021; 13:nu13124420. [PMID: 34959971 PMCID: PMC8703752 DOI: 10.3390/nu13124420] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Revised: 12/01/2021] [Accepted: 12/08/2021] [Indexed: 02/06/2023] Open
Abstract
Lack of consistency in the relationship between dairy products consumption and breast cancer (BC) risk motivated us to evaluate this association in a case-control study of BC among Polish women. The study includes 1699 women 26–79 years of age, 823 BC cases identified in Cancer Registries and 876 randomly selected controls from the national population registry. Using a validated, semiquantitative food frequency questionnaire (FFQ), the consumption of dairy products was collected for a time period of 10–15 years prior to BC diagnosis. We used logistic regression, adjusting for potential confounders, to assess the relationship between total dairy consumption as well as individual dairy groups of milk, cottage cheese and hard cheese and BC risk for premenopausal and postmenopausal women. For total consumption, a significant decrease in BC risk was observed with increased consumption of one serving/week, OR trend = 0.98, 2% decrease in risk, for premenopausal women only. For milk, a significant decrease in BC risk was observed for an increase in consumption of one glass/week, OR trend = 0.95, 5% decrease, in both strata of menopause. In contrast, for hard cheese, a significant increase in the risk of 10% was observed only in premenopausal women, OR trend = 1.10. Cottage cheese consumption significantly reduced BC risk by 20%, OR trend = 0.80, for an increase in one serving/week for postmenopausal women only. Our results show that individual dairy products have a statistically significant but bi-directional relationship with BC risk, which differs for premenopausal and postmenopausal women.
Collapse
Affiliation(s)
- Bożena Wajszczyk
- Department of Nutrition and Nutritional Value of Food, National Institute of Public Health NIH-National Research Institute, 00-791 Warszawa, Poland
- Correspondence: (B.W.); (J.C.); (D.R.P.)
| | - Jadwiga Charzewska
- Department of Nutrition and Nutritional Value of Food, National Institute of Public Health NIH-National Research Institute, 00-791 Warszawa, Poland
- Correspondence: (B.W.); (J.C.); (D.R.P.)
| | - Dariusz Godlewski
- Center of Cancer Prevention and Epidemiology OPEN, 61-863 Poznań, Poland;
| | | | | | - Maciej Kozaczka
- II Clinic of Radiology and Chemiotherapy, National Institute of Oncology, 44-102 Gliwice, Poland;
| | | | - Dorothy R. Pathak
- Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI 48824, USA
- Correspondence: (B.W.); (J.C.); (D.R.P.)
| |
Collapse
|
7
|
A Review of Breast Cancer Risk Factors in Adolescents and Young Adults. Cancers (Basel) 2021; 13:cancers13215552. [PMID: 34771713 PMCID: PMC8583289 DOI: 10.3390/cancers13215552] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2021] [Revised: 10/29/2021] [Accepted: 11/03/2021] [Indexed: 12/26/2022] Open
Abstract
Simple Summary Cancer diagnosed in patients between the ages of 15 and 39 deserves special consideration. Diagnoses within this cohort of adolescents and young adults include childhood cancers which present at an older age than expected, or an early presentation of cancers that are typically observed in older adults, such as breast cancer. Cancers within this age group are associated with worse disease-free and overall survival rates, and the incidence of these cases are rising. Knowing an individual’s susceptibility to disease can change their clinical management and allow for the risk-testing of relatives. This review discusses the risk factors that contribute to breast cancer in this unique cohort of patients, including inherited genetic risk factors, as well as environmental and lifestyle factors. We also describe risk models that allow clinicians to quantify a patient’s lifetime risk of developing disease. Abstract Cancer in adolescents and young adults (AYAs) deserves special consideration for several reasons. AYA cancers encompass paediatric malignancies that present at an older age than expected, or early-onset of cancers that are typically observed in adults. However, disease diagnosed in the AYA population is distinct to those same cancers which are diagnosed in a paediatric or older adult setting. Worse disease-free and overall survival outcomes are observed in the AYA setting, and the incidence of AYA cancers is increasing. Knowledge of an individual’s underlying cancer predisposition can influence their clinical care and may facilitate early tumour surveillance strategies and cascade testing of at-risk relatives. This information can further influence reproductive decision making. In this review we discuss the risk factors contributing to AYA breast cancer, such as heritable predisposition, environmental, and lifestyle factors. We also describe a number of risk models which incorporate genetic factors that aid clinicians in quantifying an individual’s lifetime risk of disease.
Collapse
|
8
|
He Y, Tao Q, Zhou F, Si Y, Fu R, Xu B, Xu J, Li X, Chen B. The relationship between dairy products intake and breast cancer incidence: a meta-analysis of observational studies. BMC Cancer 2021; 21:1109. [PMID: 34654387 PMCID: PMC8520314 DOI: 10.1186/s12885-021-08854-w] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2021] [Accepted: 10/08/2021] [Indexed: 12/16/2022] Open
Abstract
Background The effect of dairy products intake on breast cancer (BC) is highly controversial. This study aims to investigate the relationship between dairy intake and BC incidence. Methods A search was carried out in PubMed, EBSCO, Web of Science, and Cochrane Library databases before January 2021. The primary objective was the risk of BC and intake of dairy products were exposure variables. Results The meta-analysis comprised 36 articles with 1,019,232 participants. Total dairy products have a protective effect on female population (hazard ratio (HR) =0.95, 95% confidence interval (CI) =0.91–0.99, p = 0.019), especially for estrogen receptor-positive (ER+) (HR = 0.79, p = 0.002) and progesterone receptor-positive (PR+) BC (HR = 0.75, p = 0.027). For ER+/PR+ BC, there is a trend of protection, but it has not reached statistical significance (HR = 0.92, p = 0.075). Fermented dairy products can reduce BC risk in postmenopausal population (HR = 0.96, 95%CI = 0.93–0.99, p = 0.021), but have no protective effect on premenopausal population (HR = 0.98, 95%CI = 0.94–1.03, p = 0.52). Non-fermented dairy products have no significant effect on BC occurrence (p > 0.05). High-fat dairy products are harmful to women, without statistical difference (HR = 1.06, 95%CI = 1.00–1.13, p = 0.066). On the contrary, low-fat dairy products can protect the premenopausal population (HR = 0.94, 95%CI = 0.89–1.00, p = 0.048). Conclusion The intake of dairy products can overall reduce BC risk in the female population, but different dairy products have varying effects on different BC subtypes and menopausal status. Supplementary Information The online version contains supplementary material available at 10.1186/s12885-021-08854-w.
Collapse
Affiliation(s)
- Yujing He
- The Second Clinical Medical College, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China
| | - Qinghua Tao
- Emergency Medical Center, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China
| | - Feifei Zhou
- The Second Clinical Medical College, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China
| | - Yuexiu Si
- School of Basic Medical Sciences, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China
| | - Rongrong Fu
- The First Clinical Medical College, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China
| | - Binbin Xu
- Department of Nutrition, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China
| | - Jiaxuan Xu
- The Second Clinical Medical College, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China
| | - Xiangyuan Li
- The Second Clinical Medical College, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China
| | - Bangsheng Chen
- Emergency Medical Center, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China.
| |
Collapse
|
9
|
Velazquez FN, Viscardi V, Montemage J, Zhang L, Trocchia C, Delamont MM, Ahmad R, Hannun YA, Obeid LM, Snider AJ. A Milk-Fat Based Diet Increases Metastasis in the MMTV-PyMT Mouse Model of Breast Cancer. Nutrients 2021; 13:nu13072431. [PMID: 34371939 PMCID: PMC8308868 DOI: 10.3390/nu13072431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Revised: 07/01/2021] [Accepted: 07/12/2021] [Indexed: 11/30/2022] Open
Abstract
A high-fat diet (HFD) and obesity are risk factors for many diseases including breast cancer. This is particularly important with close to 40% of the current adult population being overweight or obese. Previous studies have implicated that Mediterranean diets (MDs) partially protect against breast cancer. However, to date, the links between diet and breast cancer progression are not well defined. Therefore, to begin to define and assess this, we used an isocaloric control diet (CD) and two HFDs enriched with either olive oil (OOBD, high in oleate, and unsaturated fatty acid in MDs) or a milk fat-based diet (MFBD, high in palmitate and myristate, saturated fatty acids in Western diets) in a mammary polyomavirus middle T antigen mouse model (MMTV-PyMT) of breast cancer. Our data demonstrate that neither MFBD or OOBD altered the growth of primary tumors in the MMTV-PyMT mice. The examination of lung metastases revealed that OOBD mice exhibited fewer surface nodules and smaller metastases when compared to MFBD and CD mice. These data suggest that different fatty acids found in different sources of HFDs may alter breast cancer metastasis.
Collapse
Affiliation(s)
- Fabiola N. Velazquez
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; (F.N.V.); (V.V.); (J.M.); (L.Z.); (C.T.); (Y.A.H.); (L.M.O.)
- Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
| | - Valentina Viscardi
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; (F.N.V.); (V.V.); (J.M.); (L.Z.); (C.T.); (Y.A.H.); (L.M.O.)
- Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
| | - Julia Montemage
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; (F.N.V.); (V.V.); (J.M.); (L.Z.); (C.T.); (Y.A.H.); (L.M.O.)
- Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
| | - Leiqing Zhang
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; (F.N.V.); (V.V.); (J.M.); (L.Z.); (C.T.); (Y.A.H.); (L.M.O.)
- Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
| | - Carolena Trocchia
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; (F.N.V.); (V.V.); (J.M.); (L.Z.); (C.T.); (Y.A.H.); (L.M.O.)
- Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
| | - Megan M. Delamont
- Department of Nutritional Sciences, College of Agriculture and Life Sciences, University of Arizona, Tucson, AZ 85721, USA;
| | - Rasheed Ahmad
- Immunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City 15462, Kuwait;
| | - Yusuf A. Hannun
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; (F.N.V.); (V.V.); (J.M.); (L.Z.); (C.T.); (Y.A.H.); (L.M.O.)
- Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
| | - Lina M. Obeid
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; (F.N.V.); (V.V.); (J.M.); (L.Z.); (C.T.); (Y.A.H.); (L.M.O.)
- Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
| | - Ashley J. Snider
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; (F.N.V.); (V.V.); (J.M.); (L.Z.); (C.T.); (Y.A.H.); (L.M.O.)
- Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
- Immunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City 15462, Kuwait;
- Correspondence: ; Tel.: +1-520-621-8093
| |
Collapse
|
10
|
Dietary Fats, Serum Cholesterol and Liver Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies. Cancers (Basel) 2021; 13:cancers13071580. [PMID: 33808094 PMCID: PMC8037522 DOI: 10.3390/cancers13071580] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2021] [Revised: 03/17/2021] [Accepted: 03/23/2021] [Indexed: 12/24/2022] Open
Abstract
Simple Summary Due to the rapid increase of primary liver cancer incidence and the poor prognosis, it is imperative to identify new modifiable factors such as diet and nutrition for the prevention of liver cancer. Diet high in saturated fatty acids (SFA) has been hypothesized to be associated with increased risk of cancers. However, the associations between dietary fatty acids and liver cancer are not consistent. We aimed to examine the association between dietary total fat, its major components, serum cholesterol, and risk of liver cancer combining current evidence from prospective studies. Our meta-analyses provided new evidence on associations between dietary fats, serum cholesterol, and liver cancer risk. Higher intake of dietary SFA was associated with higher risk of liver cancer while higher serum levels of cholesterol and high-density lipoprotein (HDL) were associated with a lower risk of liver cancer with high between-studies variability. Based on our findings, reducing dietary SFA may help to prevent the development of liver cancer. Abstract To quantify the associations between dietary fats and their major components, as well as serum levels of cholesterol, and liver cancer risk, we performed a systematic review and meta-analysis of prospective studies. We searched PubMed, Embase, and Web of Science up to October 2020 for prospective studies that reported the risk estimates of dietary fats and serum cholesterol for liver cancer risk. We carried out highest versus lowest intake or level and dose-response analyses. Higher intake of dietary saturated fatty acids (SFA) was associated with a higher liver cancer risk in both category analysis (relative risk [RR]highest vs. lowest intake = 1.34, 95% confidence interval [CI]: 1.06, 1.69) and dose-response analysis (RR1% energy = 1.04, 95%CI: 1.01, 1.07). Higher serum total cholesterol was inversely associated with liver cancer but with large between-studies variability (RR1 mmol/L = 0.72, 95%CI: 0.69, 0.75, I2 = 75.3%). The inverse association was more pronounced for serum high-density lipoprotein (HDL) cholesterol (RR1 mmol/L = 0.42, 95%CI: 0.27, 0.64). Higher intake of dietary SFA was associated with higher risk of liver cancer while higher serum levels of cholesterol and HDL were associated with a lower risk of liver cancer with high between-studies variability.
Collapse
|
11
|
Rizqiawan A, Marliyati SA, Rimbawan R. Hubungan Asupan dan Kadar Serum β-karoten, Aktivitas SOD, TNF-α dan 8-isoprostan serum dengan Ukuran Tumor Payudara. AMERTA NUTRITION 2021. [DOI: 10.20473/amnt.v5i1.2021.59-67] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Latar Belakang: Kanker payudara dapat disebabkan oleh berkembangnya Reactive Oxygen Species (ROS) di dalam sel yang memicu stres oksidatif dan oksidasi pada DNA. DNA akan kehilangan kemampuannya untuk memperbaiki diri dan terjadi mutasi. Mutasi dapat menyebabkan pertumbuhan dan perkembangan sel tumor. Asupan antioksidan seperti β-karoten pada penderita tumor dimungkinkan dapat menurunkan stres oksidatif dan risiko berkembangnya kanker.Tujuan: Penelitian ini bertujuan untuk menganalisis hubungan asupan dan kadar serum β-karoten, aktivitas SOD, TNF-α dan 8-isoprostan serum dengan ukuran tumor payudara.Metode: Penelitian ini menggunakan desain cross-sectional. Data yang digunakan adalah data baseline dari penelitian utama yang diambil pada bulan November-Desember 2018. Sebanyak 15 orang wanita yang terindikasi tumor payudara dan memenuhi kriteria inklusi serta eksklusi diikutsertakan dalam penelitian ini. Data dianalisis menggunakan uji korelasi Pearson dan spearman.Hasil: Usia subjek berkisar antara 22-52 tahun dengan rata-rata usia 36 tahun. Hasil penelitian menunjukkan asupan β-karoten per hari masih kurang. Terdapat hubungan antara asupan β-karoten dengan aktivitas SOD (p=0,025; r=0,408) dan aktivitas SOD dengan ukuran tumor payudara (p=0,018; r=-0,430). Hal ini menunjukkan bahwa terdapat hubungan tidak langsung antara asupan β-karoten dengan ukuran tumor payudara. Kadar serum β-karoten, TNF-α dan 8-isoprostan serum tidak berhubungan signifikan dengan ukuran tumor payudara (p=0,107; r=-0,430 | p=0.061; r=0,347 | p= 0,217; r=0,232).Kesimpulan: Terdapat hubungan antara asupan β-karoten dengan aktivitas SOD dan aktivitas SOD dengan ukuran tumor payudara.
Collapse
|
12
|
Aguilera-Buenosvinos I, Fernandez-Lazaro CI, Romanos-Nanclares A, Gea A, Sánchez-Bayona R, Martín-Moreno JM, Martínez-González MÁ, Toledo E. Dairy Consumption and Incidence of Breast Cancer in the 'Seguimiento Universidad de Navarra' (SUN) Project. Nutrients 2021; 13:nu13020687. [PMID: 33669972 PMCID: PMC7924827 DOI: 10.3390/nu13020687] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 02/17/2021] [Accepted: 02/18/2021] [Indexed: 01/21/2023] Open
Abstract
Dairy products might influence breast cancer (BC) risk. However, evidence is inconsistent. We sought to examine the association between dairy product consumption-and their subtypes-and incident BC in a Mediterranean cohort. The SUN ("Seguimiento Universidad de Navarra") Project is a Spanish dynamic ongoing cohort of university graduates. Dairy product consumption was estimated through a previously validated 136-item food frequency questionnaire (FFQ). Incident BC was reported in biennial follow-up questionnaires and confirmed with revision of medical records and consultation of the National Death Index. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated with Cox regression models. Among 123,297 women-years of follow-up (10,930 women, median follow-up 12.1 years), we confirmed 119 incident BC cases. We found a nonlinear association between total dairy product consumption and BC incidence (pnonlinear = 0.048) and a significant inverse association for women with moderate total dairy product consumption (HRQ2vs.Q1 = 0.49 (95% CI 0.28-0.84); HRQ3vs.Q1 = 0.49 (95% CI 0.29-0.84) ptrend = 0.623) and with moderate low-fat dairy product consumption (HRQ2vs.Q1 = 0.58 (95% CI 0.35-0.97); HRQ3vs.Q1 = 0.55 (95% CI 0.32-0.92), ptrend = 0.136). In stratified analyses, we found a significant inverse association between intermediate low-fat dairy product consumption and premenopausal BC and between medium total dairy product consumption and postmenopausal BC. Thus, dairy products, especially low-fat dairy products, may be considered within overall prudent dietary patterns.
Collapse
Affiliation(s)
- Inmaculada Aguilera-Buenosvinos
- Departamento de Medicina Preventiva y Salud Pública, Universidad de Navarra, 31008 Pamplona, Spain; (I.A.-B.); (C.I.F.-L.); (A.R.-N.); (A.G.); (M.Á.M.-G.)
| | - Cesar Ignacio Fernandez-Lazaro
- Departamento de Medicina Preventiva y Salud Pública, Universidad de Navarra, 31008 Pamplona, Spain; (I.A.-B.); (C.I.F.-L.); (A.R.-N.); (A.G.); (M.Á.M.-G.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Andrea Romanos-Nanclares
- Departamento de Medicina Preventiva y Salud Pública, Universidad de Navarra, 31008 Pamplona, Spain; (I.A.-B.); (C.I.F.-L.); (A.R.-N.); (A.G.); (M.Á.M.-G.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Alfredo Gea
- Departamento de Medicina Preventiva y Salud Pública, Universidad de Navarra, 31008 Pamplona, Spain; (I.A.-B.); (C.I.F.-L.); (A.R.-N.); (A.G.); (M.Á.M.-G.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
- Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), 28029 Madrid, Spain
| | - Rodrigo Sánchez-Bayona
- Department of Clinical Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain;
| | - Jose M. Martín-Moreno
- Department of Preventive Medicine and Public Health, Medical School & INCLIVA, University of Valencia, 46010 Valencia, Spain;
| | - Miguel Ángel Martínez-González
- Departamento de Medicina Preventiva y Salud Pública, Universidad de Navarra, 31008 Pamplona, Spain; (I.A.-B.); (C.I.F.-L.); (A.R.-N.); (A.G.); (M.Á.M.-G.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
- Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), 28029 Madrid, Spain
- Department of Nutrition, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA
| | - Estefanía Toledo
- Departamento de Medicina Preventiva y Salud Pública, Universidad de Navarra, 31008 Pamplona, Spain; (I.A.-B.); (C.I.F.-L.); (A.R.-N.); (A.G.); (M.Á.M.-G.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
- Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), 28029 Madrid, Spain
- Correspondence: ; Tel.: +34-948425600 (ext. 806224)
| |
Collapse
|
13
|
Pizato N, Hoffmann MS, Irala CH, Muniz-Junqueira MI, Silva Paixao EMD, Ito MK. Serum fatty acid synthase levels and n-3 fatty acid intake in patients with breast cancer. Clin Nutr ESPEN 2021; 42:142-147. [PMID: 33745568 DOI: 10.1016/j.clnesp.2020.12.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Revised: 11/25/2020] [Accepted: 12/15/2020] [Indexed: 11/18/2022]
Abstract
PURPOSE Fatty acid synthase (FASN) is a key enzyme in fatty acid biosynthesis that is usually over-expressed in patients with breast cancer, but its relationship with the patient's dietary habit is not clear. A higher intake of n-3 polyunsaturated fatty acids is related to reduced breast carcinogenesis in vitro and in vivo. The aim of this study was to clinically investigate the association between serum FASN levels and fatty acid intake in women newly diagnosed with breast cancer. METHODS In a case-control cross-sectional study, with 18 breast cancer patients and 29 controls, we evaluated nutritional status, dietary intake, and serum FASN levels. Statistical analyses were carried out with parametric and non-parametric tests, according to the sample's normality distribution. RESULTS The mean age of breast cancer group (n = 18) and control group (n = 29) was 46.8 ± 9.7 y and 44.4. ± 8.6 y, respectively. Mean serum concentration of FASN in breast cancer group was significantly higher (132.51 ± 95.05 ng/mL) than in control group (36.88 ± 20.87 ng/mL) (p < 0.0001). Among breast cancer group, serum FASN levels of premenopausal women were significantly higher than those of postmenopausal women (p = 0.026). There was no significant difference between the early and late disease stages in regard to serum FASN levels in breast cancer group. Mean nutrient intake was similar and n-3 docosahexaenoic acid intake was low in both groups. We observed no association regarding fatty acid intake and serum FASN levels. CONCLUSION These data suggest that dietary n-3 fatty acid has no association with serum FASN levels among newly diagnosed breast cancer patients.
Collapse
Affiliation(s)
- Nathalia Pizato
- Graduate Program in Human Nutrition, Department of Nutrition, University of Brasilia, UnB, Brasilia 70910-900, Brazil.
| | - Meg Schwarcz Hoffmann
- University Hospital of Brasilia, University of Brasília, UnB, Brasilia 70910-900, Brazil.
| | - Clarissa Hoffman Irala
- University Hospital of Brasilia, University of Brasília, UnB, Brasilia 70910-900, Brazil.
| | | | | | - Marina Kiyomi Ito
- Graduate Program in Human Nutrition, Department of Nutrition, University of Brasilia, UnB, Brasilia 70910-900, Brazil.
| |
Collapse
|
14
|
Costantino G, Calasso M, Minervini F, De Angelis M. Use of Exopolysaccharide-Synthesizing Lactic Acid Bacteria and Fat Replacers for Manufacturing Reduced-Fat Burrata Cheese: Microbiological Aspects and Sensory Evaluation. Microorganisms 2020; 8:microorganisms8101618. [PMID: 33096692 PMCID: PMC7588969 DOI: 10.3390/microorganisms8101618] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2020] [Revised: 10/17/2020] [Accepted: 10/18/2020] [Indexed: 12/19/2022] Open
Abstract
This study aimed to set-up a biotechnological protocol for manufacturing a reduced-fat Burrata cheese using semi-skimmed milk and reduced-fat cream, in different combinations with exopolysaccharides-synthesizing bacterial starters (Streptococcus thermophilus, E1, or Lactococcus lactis subsp. lactis and Lc. lactis subsp. cremoris, E2) and carrageenan or xanthan. Eight variants of reduced-fat cheese (fat concentration 34–51% lower than traditional full-fat Burrata cheese, used as the control) were obtained using: (i) semi-skimmed milk and reduced-fat cream alone (RC) or in combination with (ii) xanthan (RCX), (iii) carrageenan (RCC), (iv) starter E1 (RCE1), (v) starter E2 (RCE2), (vi) both starters (RCE1-2), (vii) E1 and xanthan (RCXE1), or E1 and carrageenan (RCCE1). Post-acidification occurred for the RCC, RCX, and RCE2 Burrata cheeses, due to the higher number of mesophilic cocci found in these cheeses after 16 days of storage. Overall, mesophilic and thermophilic cocci, although showing cheese variant-depending dynamics, were dominant microbial groups, flanked by Pseudomonas sp. during storage. Lactobacilli, increasing during storage, represented another dominant microbial group. The panel test gave highest scores to RCE1-2 and RCXE1 cheeses, even after 16 days of storage. The 16S-targeted metagenomic analysis revealed that a core microbiota (S. thermophilus, Streptococcus lutetiensis, Lc. lactis, Lactococcus sp., Leuconostoc lactis, Lactobacillus delbrueckii, and Pseudomonas sp.), characterized the Burrata cheeses. A consumer test, based on 105 people, showed that more than 50% of consumers did not distinguish the traditional full-fat from the RCXE1 reduced-fat Burrata cheese.
Collapse
|
15
|
Li X, Zhou C, Wu Y, Chen X. Relationship between formulaic breast volume and risk of breast cancer based on linear measurements. BMC Cancer 2020; 20:989. [PMID: 33046044 PMCID: PMC7552486 DOI: 10.1186/s12885-020-07499-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2020] [Accepted: 10/06/2020] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Whether breast volume is a risk factor for breast cancer is controversial. This study aimed to evaluate whether a significant association between breast volume and risk of breast cancer, based on linear measurements, was present by applying propensity score matching (PSM). METHODS The study was designed as a hospital-based case-control study. Between March 2018 and May 2019, 208 cases and 340 controls were retrospectively reviewed. Information on menarche, smoking, feeding mode, oral contraceptives, reproductive history and family history was obtained through a structured questionnaire. Breast volume was calculated using a formula based on linear measurements of breast parameters. Cox regression and PSM were used to estimate odds ratios and 95% confidence intervals for breast cancer using risk factors adjusted for potential confounders. RESULTS There was a significant difference in breast volume between the two groups before propensity score matching (P = 0.014). Binary logistic regression showed that the risk of breast cancer was slightly higher in the case group with larger breast volumes than in the control group(P = 0.009, OR = 1.002, 95%CI:1.000 ~ 1.003). However, there was no significant statistical difference between the two groups using an independent sample Mann-Whitney U test (P = 0.438) or conditional logistic regression (P = 0.446). CONCLUSIONS After PSM for potential confounding factors, there is no significant difference in breast volume estimated by BREAST-V formula between the case group and the control group. The risk of breast cancer may not be related to breast volume in Chinese women.
Collapse
Affiliation(s)
- Xiaoxia Li
- Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Road, Guangzhou, Guangdong 510515 P. R. China
| | - Chunlan Zhou
- Department of Nursing, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Road, Guangzhou, Guangdong 510515 P. R. China
| | - Yanni Wu
- Department of Nursing, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Road, Guangzhou, Guangdong 510515 P. R. China
| | - Xiaohong Chen
- Department of Thyroid Breast Surgery, the First Affiliated Hospital of Shantou University Medical College, 57 Changping Road, Shantou, Guangdong 515041 P. R. China
| |
Collapse
|
16
|
Kulathunga N, Kohno S, Linn P, Nishimoto Y, Horike SI, Zaraiskii MI, Kumar S, Muranaka H, Takahashi C. Peripubertal high-fat diet promotes c-Myc stabilization in mammary gland epithelium. Cancer Sci 2020; 111:2336-2348. [PMID: 32437590 PMCID: PMC7385354 DOI: 10.1111/cas.14492] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2020] [Revised: 05/14/2020] [Accepted: 05/16/2020] [Indexed: 12/12/2022] Open
Abstract
Dietary fat consumption during accelerated stages of mammary gland development, such as peripubertal maturation or pregnancy, is known to increase the risk for breast cancer. However, the underlying molecular mechanisms are not fully understood. Here we examined the gene expression profile of mouse mammary epithelial cells (MMECs) on exposure to a high-fat diet (HFD) or control diet (CD). Trp53-/- female mice were fed with the experimental diets for 5 weeks during the peripubertal period (3-8 weeks of age). The treatment showed no significant difference in body weight between the HFD-fed mice and CD-fed mice. However, gene set enrichment analysis predicted a significant enrichment of c-Myc target genes in animals fed HFD. Furthermore, we detected enhanced activity and stabilization of c-Myc protein in MMECs exposed to a HFD. This was accompanied by augmented c-Myc phosphorylation at S62 with a concomitant increase in ERK phosphorylation. Moreover, MMECs derived from HFD-fed Trp53-/- mouse showed increased colony- and sphere-forming potential that was dependent on c-Myc. Further, oleic acid, a major fatty acid constituent of the HFD, and TAK-875, an agonist to G protein-coupled receptor 40 (a receptor for oleic acid), enhanced c-Myc stabilization and MMEC proliferation. Overall, our data indicate that HFD influences MMECs by stabilizing an oncoprotein, pointing to a novel mechanism underlying dietary fat-mediated mammary carcinogenesis.
Collapse
Affiliation(s)
- Nilakshi Kulathunga
- Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
| | - Susumu Kohno
- Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
| | - Paing Linn
- Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
| | - Yuuki Nishimoto
- Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
| | - Shin-Ichi Horike
- Advanced Science Research Center, Kanazawa University, Kanazawa, Japan
| | - Mikhail I Zaraiskii
- Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia
| | - Sharad Kumar
- Centre for Cancer Biology, University of South Australia, Adelaide, SA, Australia
| | - Hayato Muranaka
- Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.,Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Chiaki Takahashi
- Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
| |
Collapse
|
17
|
Tayyem RF, Mahmoud RI, Marei LS. The Intake of Some Nutrients is Associated with the Risk of Breast Cancer: Results from Jordanian Case-Control Study. CURRENT RESEARCH IN NUTRITION AND FOOD SCIENCE JOURNAL 2020. [DOI: 10.12944/crnfsj.8.1.02] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Breast cancer (BC) is the most commonly diagnosed cancer and is
considered the leading cause of cancer deaths in women globally. The aim
of this study is to evaluate the relationship between macro- and micronutrient
intake and BC risk among Jordanian women. A case-control design was used
in this study, and BC patients were recruited from the main two hospitals
provide cancer therapy in Jordan. Four hundred women aged 20-65 years
of age were enrolled in the study. For the cases, 200 recently diagnosed
BC women were selected from the two hospitals and matched in age and
marital status to 200 BC-free women. Dietary data were collected through
face-to-face interview using a validated food frequency questionnaire
between October 2016 and September 2017. To calculate odds ratio
(OR), logistic regression was used; while for p-trend the linear regression
was performed. The study results demonstrated that increasing the intake
of total energy and percentage of fat was significantly and positively
associated with BC (p-= 0.001). The risk of BC increased significantly and
positively as carbohydrate, sugar, fat, saturated fat and polyunsaturated
and monounsaturated fatty acids intake increased. A significant trend in
BC risk was found for cholesterol (p-= 0.005). The ORs for higher intakes
of vitamins E, B1, B2, and B3, folate and phosphorus showed a significant
association with the risk of BC (p-trend =0.001). A significant inverse effect
was detected between iron intake and BC risk (p-=0.001). The study findings
resulted in insight of the associations between the total energy intake and
some macro/micronutrients intake can be an increasing risk of BC.
Collapse
Affiliation(s)
- Reema F. Tayyem
- Department of Nutrition and Food Technology, Faculty of Agriculture, The University of Jordan. Amman 11942 Jordan
| | - Reema I. Mahmoud
- Department of Nutrition and Food Technology, Faculty of Agriculture, The University of Jordan
| | | |
Collapse
|
18
|
Shetty PJ, Sreedharan J. Breast Cancer and Dietary Fat Intake: A correlational study. Nepal J Epidemiol 2019; 9:812-816. [PMID: 31970016 PMCID: PMC6964800 DOI: 10.3126/nje.v9i4.26961] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2019] [Revised: 10/13/2019] [Accepted: 11/12/2019] [Indexed: 12/27/2022] Open
Abstract
Background: Breast cancer (BC) is reported to be the most common malignancies affecting women worldwide. There is a sharp increase in the BC incidence rate over the past three decades as previously low risk countries are moving towards high -calorie western diets. Few epidemiologic studies along with animal experiments have ascertained the role of dietary fat in developing BC. This study aimed to determine the correlation between per capita dietary fat consumption and incidence of BC. Methods: Three major data bases were used to conduct this correlational study. The data regarding consumption of fat and breast cancer incidence from 88 countries across five continents were extracted. The correlation coefficients between the incidence of BC and the fat consumption from the year 1990 to 2007 were calculated. Results: A statistically significant (P<0.001) correlation between the average fat consumption and the crude BC incidence rate was observed and was more than 0.6, clearly indicating that there is a moderate to strong correlation with fat consumption and incidence of breast cancer (P<0.001). Conclusions: Our observation indicated that increased total fat consumption increases the risk of developing BC. Consumption of dietary fat increases obesity thereby, increasing the risk of BC development. Dietary fat gets stored in the body since they undergo minimum oxidation as compared to carbohydrates and protein thereby, contributing to obesity a known risk factors for BC. Current study strengthens the evidence to support the hypothesis that non-genetic factors contribute to the occurrence of this disease.
Collapse
Affiliation(s)
- Preetha J Shetty
- Associate Professor, Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates
| | - Jayadevan Sreedharan
- Professor, Department of Community Medicine, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates
| |
Collapse
|
19
|
Shin WK, Lee HW, Shin A, Lee JK, Kang D. Milk Consumption Decreases Risk for Breast Cancer in Korean Women under 50 Years of Age: Results from the Health Examinees Study. Nutrients 2019; 12:E32. [PMID: 31877693 PMCID: PMC7019619 DOI: 10.3390/nu12010032] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Revised: 12/16/2019] [Accepted: 12/17/2019] [Indexed: 12/24/2022] Open
Abstract
Epidemiologic studies regarding breast cancer risk related to milk consumption remain controversial. The aim of this study was to evaluate the association between milk consumption and the risk for breast cancer. A total of 93,306 participants, aged 40-69 years, were included in the prospective cohort study in the Health Examinees-Gem (HEXA-G) study between 2004 and 2013. Dietary intake was assessed using a validated food frequency questionnaire. Information on cancer diagnosis in the eligible cohort was retrieved from the Korea Central Cancer Registry through 31 December 2014. The Cox proportional hazards model was used to estimate multivariate hazard ratios (HRs) and 95% confidence intervals (CIs). A total of 359 breast cancer cases were observed over a median follow-up period of 6.3 years. Milk consumption was not associated with decreased risk for breast cancer in the total population (p for trend = 0.0687). In women under 50 years of age, however, milk consumption was inversely associated with breast cancer risk. In the comparison between highest (≥1 serving/day) and lowest (<1 serving/week) intake categories of milk, the multivariate HR (95% CI) was 0.58 (0.35-0.97, p for trend = 0.0195)) among women under 50 years of age. In conclusion, our findings show that milk consumption in Korean women aged 50 or younger is associated with a decreased risk for breast cancer, when compared to those who never or rarely consumed milk. Further studies need to be conducted to assess this relationship and confirm these results.
Collapse
Affiliation(s)
- Woo-Kyoung Shin
- Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea; (W.-K.S.); (H.-W.L.); (A.S.)
| | - Hwi-Won Lee
- Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea; (W.-K.S.); (H.-W.L.); (A.S.)
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea
| | - Aesun Shin
- Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea; (W.-K.S.); (H.-W.L.); (A.S.)
- Cancer Research Institute, Seoul National University, Seoul 03080, Korea
| | - Jong-koo Lee
- Department of Family Medicine, Seoul National University Hospital, Seoul 03080, Korea;
| | - Daehee Kang
- Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea; (W.-K.S.); (H.-W.L.); (A.S.)
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea
- Cancer Research Institute, Seoul National University, Seoul 03080, Korea
| |
Collapse
|
20
|
Argyridou S, Zaccardi F, Davies MJ, Khunti K, Yates T. Relevance of physical function in the association of red and processed meat intake with all-cause, cardiovascular, and cancer mortality. Nutr Metab Cardiovasc Dis 2019; 29:1308-1315. [PMID: 31377183 DOI: 10.1016/j.numecd.2019.06.019] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/04/2019] [Revised: 06/18/2019] [Accepted: 06/21/2019] [Indexed: 12/11/2022]
Abstract
BACKGROUND AND AIMS Intake of red and processed meat has been associated with a higher risk of morbidity and mortality; it is unknown whether these associations are modified by overall physical health. This study examined the associations of red and processed meat consumption with all-cause, cardiovascular, and cancer mortality and investigated whether markers of physical function modified the associations. METHODS AND RESULTS This observational cohort study used UK Biobank data derived from 419,075 participants free from cancer and cardiovascular disease. Cox models assessed the association of red and processed meat consumption (obtained from a baseline food frequency questionnaire) with mortality, adjusted for potential confounders. Objectively measured handgrip strength and self-reported walking pace were used as interaction terms. The median age was 57 (interquartile range, 49-63) years and 54.9% were women. Over 7 years of follow-up, 8586 all-cause, 1660 cardiovascular, and 4812 cancer deaths occurred. Each additional serving per week of red and processed meat was associated with a hazard ratio (HR) of 1.037 (95% CI: 1.028-1.047) for all-cause; 1.030 (1.009-1.051) for cardiovascular; and 1.029 (1.016-1.042) for cancer mortality. The association of red and processed meat consumption was modified by walking pace, with brisk walkers having the lowest risk per additional serving for all-cause and cancer mortality (HR 1.025; 1.006-1.045 and 1.015; 0.990-1.040, respectively); no interaction was observed for handgrip strength. CONCLUSION The known risk of mortality associated with red and processed meat consumption may be lower in those with high physical function.
Collapse
Affiliation(s)
- Stavroula Argyridou
- Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Rd, Leicester, LE5 4PW, UK; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, LE1 7RH, UK.
| | - Francesco Zaccardi
- Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Rd, Leicester, LE5 4PW, UK
| | - Melanie J Davies
- Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Rd, Leicester, LE5 4PW, UK; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, LE1 7RH, UK
| | - Kamlesh Khunti
- Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Rd, Leicester, LE5 4PW, UK; NIHR Collaboration for Leadership in Applied Health Research and Care-East Midlands, University of Leicester, Leicester, LE1 7RH, UK
| | - Thomas Yates
- Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Rd, Leicester, LE5 4PW, UK; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, LE1 7RH, UK
| |
Collapse
|
21
|
Elhassan M, Gandhi KD, Sandhu C, Hashmi M, Bahl S. Internal medicine residents' point-of-care ultrasound skills and need assessment and the role of medical school training. ADVANCES IN MEDICAL EDUCATION AND PRACTICE 2019; 10:379-386. [PMID: 31213943 PMCID: PMC6549795 DOI: 10.2147/amep.s198536] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/17/2018] [Accepted: 04/10/2019] [Indexed: 05/02/2023]
Abstract
Introduction: Point-of-care-ultrasound (POCUS) as a useful bedside tool is growing. Few studies have examined residents' attitude towards POCUS or compared POCUS image interpretation skills between residents with and without POCUS training in medical school. Material and Methods: We distributed an anonymous survey and image interpretation test to assess residents' attitude towards POCUS, confidence, and skills in interpreting POCUS images and videos. Using independent samples t-tests, we compared mean confidence levels and test scores between residents with and without prior POCUS training. Results: Fifty-two residents responded to survey (response rate 68%) and 59 took the image interpretation test (77%). Most residents (90%) reported being interested in POCUS. Residents with prior POCUS training (n=13) were either PGY-1 (9) or PGY-2 (4). No PGY-3 resident had prior training. Most residents (83%) thought POCUS could be extremely useful in the inpatient setting compared to 29% for outpatient setting. PGY-1 residents with prior training had a higher mean confidence level than PGY-1 residents without prior training, but the difference was not statistically significant (3.26 vs 2.64; p=0.08). PGY-1 with prior training had a mean confidence level that was close to that of PGY-3 residents. PGY-1 residents with prior training scored significantly higher than PGY-1 residents without prior training in image interpretation test (10.25 vs 7; p=0.01). Residents felt most confident in interpreting inferior vena cava images (mean 3.7; max. 5), which also had the highest score in image interpretation test (correct response rate of 88%). Conclusion: Our residents seem very interested in POCUS. PGY-1 residents with prior POCUS training in medical school seem to have higher confidence in their POCUS skills than PGY-1 residents without prior training and outperformed them in image interpretation test. The study is very instructive in building our future POCUS curriculum for residents.
Collapse
Affiliation(s)
- Mohammed Elhassan
- Department of Internal Medicine, UCSF Fresno Medical Education Program, Fresno, CA, USA
| | - Kevin D Gandhi
- Department of Internal Medicine, UCSF Fresno Medical Education Program, Fresno, CA, USA
| | - Charnjeet Sandhu
- Department of Internal Medicine, UCSF Fresno Medical Education Program, Fresno, CA, USA
| | - Mohammad Hashmi
- Department of Internal Medicine, UCSF Fresno Medical Education Program, Fresno, CA, USA
| | - Sameer Bahl
- Department of Internal Medicine, UCSF Fresno Medical Education Program, Fresno, CA, USA
| |
Collapse
|
22
|
Goncalves MD, Hopkins BD, Cantley LC. Dietary Fat and Sugar in Promoting Cancer Development and Progression. ANNUAL REVIEW OF CANCER BIOLOGY-SERIES 2019. [DOI: 10.1146/annurev-cancerbio-030518-055855] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The uncontrolled cellular growth that characterizes tumor formation requires a constant delivery of nutrients. Since the 1970s, researchers have wondered if the supply of nutrients from the diet could impact tumor development. Numerous studies have assessed the impact of dietary components, specifically sugar and fat, to increased cancer risk. For the most part, data from these trials have been inconclusive; however, this does not indicate that dietary factors do not contribute to cancer progression. Rather, the dietary contribution may be dependent on tumor, patient, and context, making it difficult to detect in the setting of large trials. In this review, we combine data from prospective cohort trials with mechanistic studies in mice to argue that fat and sugar can play a role in tumorigenesis and disease progression. We find that certain tumors may respond directly to dietary sugar (colorectal and endometrial cancers) and fat (prostate cancer) or indirectly to the obese state (breast cancer).
Collapse
Affiliation(s)
- Marcus D. Goncalves
- Meyer Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA;, ,
- Division of Endocrinology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA
| | - Benjamin D. Hopkins
- Meyer Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA;, ,
| | - Lewis C. Cantley
- Meyer Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA;, ,
| |
Collapse
|
23
|
The DAMA Trial: A Diet and Physical Activity Intervention Trial to Reduce Mammographic Breast Density in Postmenopausal Women in Tuscany, Italy. Study Protocol and Baseline Characteristics. TUMORI JOURNAL 2018. [DOI: 10.1177/1636.17890] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
24
|
Villarini A, Pasanisi P, Traina A, Mano MP, Bonanni B, Panico S, Scipioni C, Galasso R, Paduos A, Simeoni M, Bellotti E, Barbero M, Macellari G, Venturelli E, Raimondi M, Bruno E, Gargano G, Fornaciari G, Morelli D, Seregni E, Krogh V, Berrino F. Lifestyle and Breast Cancer Recurrences: The DIANA-5 Trial. TUMORI JOURNAL 2018; 98:1-18. [DOI: 10.1177/030089161209800101] [Citation(s) in RCA: 69] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Aims and Background The DIANA (Diet and Androgens)-5 study is a multi-institutional randomized controlled trial of the effectiveness of a diet based on Mediterranean and macrobiotic recipes and principles, associated with moderate physical activity, in reducing additional breast cancer events in women with early stage invasive breast cancer at high risk of recurrence because of metabolic or endocrine milieu. The intervention is expected to reduce serum insulin and sex hormones, which were associated with breast prognosis in previous studies. Methods Between 2008 and 2010, the study randomly assigned 1208 patients to an intensive diet and exercise intervention or to a comparison group, to be followed-up through 2015. General lifestyle recommendations for the prevention of cancer are given to both groups, and the intervention group is being offered a comprehensive lifestyle intervention, including cooking classes, conferences, common meals and exercise sessions. Adherence assessments occurred at baseline and at 12 months and are planned at 36 and 60 months. They include food frequency diaries, anthropometric measures, body fat distribution assessed with impedance scale, one week registration of physical activity with a multisensor arm-band monitor, metabolic and endocrine blood parameters. Outcome breast cancer events are assessed through self report at semi annual meetings or telephone interview and are validated through medical record verification. Results The randomized groups were comparable for age (51.8 years), proportion of ER-negative tumors (22%), axillary node metastasis (42%), reproductive variables, tobacco smoking, blood pressure, anthropometric measurements and hormonal and metabolic parameters. Conclusions DIANA-5 has the potential to establish whether a Mediterranean-macrobiotic lifestyle may reduce breast cancer recurrences. We will assess evidence of effectiveness, first by comparing the incidence of additional breast cancer events (local or distant recurrence, second ipsilateral or contralateral cancer) in the intervention and in the control group, by an intention-to-treat analysis, and second by analyzing the incidence of breast cancer events in the total study population by compliance assessment score.
Collapse
Affiliation(s)
- Anna Villarini
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - Patrizia Pasanisi
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - Adele Traina
- Department of Oncology ARNAS Ospedali Civico e Benfratelli G. Di Cristina e M. Ascoli, Palermo
| | - Maria Piera Mano
- Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO), Turin
| | | | - Salvatore Panico
- Department of Clinical and Experimental Medicine, Università Federico II, Naples
| | - Corrado Scipioni
- Centro di Prevenzione, Diagnosi e Terapia del Tumore alla Mammella “Giunone”, Avezzano, L'Aquila
| | - Rocco Galasso
- Department of Oncology, Centro di Riferimento Oncologico, Rionero in Vulture (Potenza)
| | | | | | - Elena Bellotti
- Unit of Radiology, Azienda Ospedaliera di Busto Arsizio (Varese)
| | | | | | - Elisabetta Venturelli
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - Milena Raimondi
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - Eleonora Bruno
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - Giuliana Gargano
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - Giuseppe Fornaciari
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - Daniele Morelli
- Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - Ettore Seregni
- Department of Diagnostic Imaging and Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - Vittorio Krogh
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - Franco Berrino
- Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| |
Collapse
|
25
|
Yang JJ, Yu D, Takata Y, Smith-Warner SA, Blot W, White E, Robien K, Park Y, Xiang YB, Sinha R, Lazovich D, Stampfer M, Tumino R, Aune D, Overvad K, Liao L, Zhang X, Gao YT, Johansson M, Willett W, Zheng W, Shu XO. Dietary Fat Intake and Lung Cancer Risk: A Pooled Analysis. J Clin Oncol 2017; 35:3055-3064. [PMID: 28742456 PMCID: PMC5590804 DOI: 10.1200/jco.2017.73.3329] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Purpose Dietary fat may play a role in lung carcinogenesis. Findings from epidemiologic studies, however, remain inconsistent. In this pooled analysis of 10 prospective cohort studies from the United States, Europe, and Asia, we evaluated the associations of total and specific types of dietary fat with lung cancer risk. Methods Cox regression was used to estimate hazard ratios (HRs) and 95% CIs in each cohort. Study-specific risk estimates were pooled by random- or fixed-effects meta-analysis. The first 2 years of follow-up were excluded to address potential influence of preclinical dietary changes. Results Among 1,445,850 participants, 18,822 incident cases were identified (mean follow-up, 9.4 years). High intakes of total and saturated fat were associated with an increased risk of lung cancer (for highest v lowest quintile: HR, 1.07 and 1.14, respectively; 95% CI, 1.00 to 1.15 and 1.07 to 1.22, respectively; P for trend for both < .001). The positive association of saturated fat was more evident among current smokers (HR, 1.23; 95% CI, 1.13 to 1.35; P for trend < .001) than former/never smokers ( P for interaction = .004), and for squamous cell and small cell carcinoma (HR, 1.61 and 1.40, respectively; 95% CI, 1.38 to 1.88 and 1.17 to 1.67, respectively; P for trend for both < .001) than other histologic types ( P for heterogeneity < .001). In contrast, a high intake of polyunsaturated fat was associated with a decreased risk of lung cancer (HR, 0.92; 95% CI, 0.87 to 0.98 for highest v lowest quintile; P for trend = .02). A 5% energy substitution of saturated fat with polyunsaturated fat was associated with a 16% to 17% lower risk of small cell and squamous cell carcinoma. No associations were found for monounsaturated fat. Conclusion Findings from this large, international cohort consortium suggest that modifying dietary fat intake (ie, replacing saturated fat with polyunsaturated fat) may reduce lung cancer risk, particularly among smokers and for squamous cell and small cell carcinoma.
Collapse
Affiliation(s)
- Jae Jeong Yang
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Danxia Yu
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Yumie Takata
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Stephanie A. Smith-Warner
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - William Blot
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Emily White
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Kim Robien
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Yikyung Park
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Yong-Bing Xiang
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Rashmi Sinha
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - DeAnn Lazovich
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Meir Stampfer
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Rosario Tumino
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Dagfinn Aune
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Kim Overvad
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Linda Liao
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Xuehong Zhang
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Yu-Tang Gao
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Mattias Johansson
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Walter Willett
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Wei Zheng
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| | - Xiao-Ou Shu
- Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
| |
Collapse
|
26
|
Shapira N. The potential contribution of dietary factors to breast cancer prevention. Eur J Cancer Prev 2017; 26:385-395. [PMID: 28746163 PMCID: PMC5553235 DOI: 10.1097/cej.0000000000000406] [Citation(s) in RCA: 45] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2017] [Revised: 06/21/2017] [Indexed: 12/30/2022]
Abstract
Breast cancer (BC), the leading cancer in women, is increasing in prevalence worldwide, concurrent with western metabolic epidemics, that is, obesity, metabolic syndrome, and diabetes, and shares major risk factors with these diseases. The corresponding potential for nutritional contributions toward BC prevention is reviewed and related to critical stages in the life cycle and their implications for carcinogenic and pathometabolic trajectories. BC initiation potentially involves diet-related pro-oxidative, inflammatory, and procarcinogenic processes, that interact through combined lipid/fatty acid peroxidation, estrogen metabolism, and related DNA-adduct/depurination/mutation formation. The pathometabolic trajectory is affected by high estrogen, insulin, and growth factor cascades and resultant accelerated proliferation/progression. Anthropometric risk factors - high birth weight, adult tallness, adiposity/BMI, and weight gain - are often reflective of these trends. A sex-based nutritional approach targets women's specific risk in western obesogenic environments, associated with increasing fatness, estrogen metabolism, n-6 : n-3 polyunsaturated fatty acid ratio, and n-6 polyunsaturated fatty acid conversion to proinflammatory/carcinogenic eicosanoids, and effects of timing of life events, for example, ages at menarche, full-term pregnancy, and menopause. Recent large-scale studies have confirmed the effectiveness of the evidence-based recommendations against BC risk, emphasizing low-energy density diets, highly nutritious plant-based regimes, physical activity, and body/abdominal adiposity management. Better understanding of dietary inter-relationships with BC, as applied to food intake, selection, combination, and processing/preparation, and recommended patterns, for example, Mediterranean, DASH, plant-based, low energy density, and low glycemic load, with high nutrient/phytonutrient density, would increase public motivation and authoritative support for early/timely prevention, optimally merging with other dietary/health goals, for lifelong BC prevention.
Collapse
Affiliation(s)
- Niva Shapira
- Department of Nutrition, School of Health Professions, Ashkelon Academic College, Ashkelon, Israel
| |
Collapse
|
27
|
Abstract
Benign breast disease is a spectrum of common disorders. The majority of patients with a clinical breast lesion will have benign process. Management involves symptom control when present, pathologic-based and imaging-based evaluation to distinguish from a malignant process, and counseling for patients that have an increased breast cancer risk due to the benign disorder.
Collapse
|
28
|
The association between the Index of Nutritional Quality (INQ) and breast cancer and the evaluation of nutrient intake of breast cancer patients: A case-control study. Nutrition 2017; 45:11-16. [PMID: 29129231 DOI: 10.1016/j.nut.2017.06.011] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Revised: 06/17/2017] [Accepted: 06/29/2017] [Indexed: 01/07/2023]
Abstract
OBJECTIVE Breast cancer (BrCa) is the most frequently diagnosed cancer among females and second cancer after lung cancer in many societies. In Iran, the risk for BrCa is 1 in 35 and each year, 8000 new patients have been diagnosed with BrCa. Studies have shown that dietary components are implicated in the etiology of BrCa. The Index of Nutritional Quality (INQ) is a method of quantitative and qualitative analysis of single foods, meals, and diets. The aim of this study was to determine the usefulness of INQs in predicting BrCa risk. METHODS Our case-control study was conducted from March 2015 to February 2016. The study included 145 cases and 148 controls who attended the Shahid Beheshti University of Medical Sciences Cancer Research Center. INQ scores were computed based on dietary intake using a validated 168-item food frequency questionnaire. Logistic regression models were used to estimate multivariable odds ratios adjusted body mass index, education, employment, marital status, menarche age, childbirth number, smoking, menopause status, and physical activity. RESULTS Vitamins A, C, B1, B2, and B12 and selenium INQs as a continuous variable in relation to risk for BrCa showed a significant association after multivariate adjustment (odds ratio [OR]vitA, 0.41 [0.27-0.64]; ORvitC, 0.30 [0.20-0.47]; ORvitB1, 0.08 [0.04-0.17]; ORvitB2, 0.19 [0.11-0.34]; ORvitB12, 0.44 [0.31-0.61]; and ORselenium, 0.42 [0.26-0.67]). CONCLUSION Women who consumed a healthier diet including vitamin A, β-carotene, vitamin C, and folate and low-fat milk were at decreased risk for developing BrCa compared with those whose diet included more high fat and lamb meat.
Collapse
|
29
|
Akinyemiju T, Moore JX, Pisu M, Lakoski SG, Shikany J, Goodman M, Judd SE. A prospective study of dietary patterns and cancer mortality among Blacks and Whites in the REGARDS cohort. Int J Cancer 2016; 139:2221-31. [PMID: 27459634 PMCID: PMC5041524 DOI: 10.1002/ijc.30287] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2016] [Revised: 06/12/2016] [Accepted: 07/18/2016] [Indexed: 12/20/2022]
Abstract
Marked racial differences exist in dietary patterns and obesity, as well as cancer mortality. This study aims to assess whether dietary patterns are associated with cancer mortality overall and by race. We identified 22,041 participants from the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. Dietary patterns were categorized into: Convenience (Chinese and Mexican foods, pasta, pizza), Plant-based (fruits, vegetables), Southern (added fats, fried foods, sugar-sweetened beverages), Sweets/Fats (sugary foods) and Alcohol/Salads (alcohol, green-leafy vegetables, salad dressing). Using Cox regression, we examined the association between quartiles of dietary patterns and cancer mortality, adjusted for potential confounders, overall among all participants and stratified by race. A total of 873 cancer deaths were observed over the 10-year observation period: 582 (66.7%) in Whites and 291 (33.3%) in Blacks. Greater adherence to the Southern dietary pattern was associated with an increased risk of cancer mortality (4th vs. 1st quartile HR: 1.67; 95% CI: 1.32-2.10) overall, especially among Whites (4th vs. 1st quartile HR: 1.59; 95% CI: 1.22-2.08). The convenience (HR: 0.73; 95% CI: 0.56-0.94) and Plant-based (HR: 0.72; 95% CI: 0.55-0.93) dietary patterns were associated with up to a 28% reduced risk of cancer mortality, but only among Whites. Greater adherence to the Southern dietary pattern increased the risk of cancer mortality, while greater adherence to the convenience and Plant-based diets reduced the risk of cancer mortality among Whites. Racial differences were observed in the association between dietary patterns and cancer mortality, but warrant further study.
Collapse
Affiliation(s)
- Tomi Akinyemiju
- Departments of Epidemiology, University of Alabama at Birmingham, Birmingham, AL.
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL.
| | - Justin Xavier Moore
- Departments of Epidemiology, University of Alabama at Birmingham, Birmingham, AL
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
| | - Maria Pisu
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
- Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL
| | - Susan G Lakoski
- Department of Clinical Cancer Prevention and Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - James Shikany
- Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL
| | - Michael Goodman
- Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA
| | - Suzanne E Judd
- Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL
| |
Collapse
|
30
|
Role of high-fat diet on the effect of pioglitazone and melatonin in a rat model of breast cancer. Eur J Cancer Prev 2016; 25:395-403. [DOI: 10.1097/cej.0000000000000195] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
31
|
|
32
|
Bassett JK, Hodge AM, English DR, MacInnis RJ, Giles GG. Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk. Cancer Causes Control 2016; 27:759-73. [PMID: 27146840 DOI: 10.1007/s10552-016-0753-2] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2016] [Accepted: 04/22/2016] [Indexed: 10/21/2022]
Abstract
PURPOSE This study prospectively investigates associations between fatty acids assessed in plasma phospholipids (PPL) and diet, and breast cancer risk, including subgroups defined by hormone receptor status. METHODS We performed a case-cohort analysis within the Melbourne Collaborative Cohort Study using a random sample of 2,021 women and 470 breast cancer cases. At baseline, fatty acids were assessed in PPL and estimated from diet using a 121-item food frequency questionnaire. Hazard ratios (HR) and 95 % confidence intervals (CI) were estimated using Cox regression. RESULTS Breast cancer risk was positively associated with %PPL saturated fatty acids (SFA); HRQ5vsQ1 = 1.64 (95 % CI 1.17-2.30); p trend = 0.004. Positive associations were found for ER+ or PR+ tumors for %PPL SFA and palmitic acid and for ER-/PR- tumors for %PPL n-6 polyunsaturated fatty acid (PUFA), TFA, TFA 16:1, and TFA 18:1n-7 (all p homogeneity <0.05). Breast cancer risk was inversely associated with dietary docosapentaenoic acid (DPA); HRQ5vsQ1 = 0.57 (95 % CI 0.40-0.82); p trend = 0.001 [with similar inverse associations observed for dietary docosahexaenoic (DHA) and eicosapentaenoic acid (EPA)] and positively associated with dietary n-6:n-3 PUFA. Inverse associations for ER-/PR- tumors were found for dietary dihomo-γ-linolenic acid (DGLA) for older women (p homogeneity = 0.04). CONCLUSIONS Breast cancer risk was positively associated with %PPL SFA and the ratio of dietary n-6 to n-3 PUFA and inversely associated with dietary long-chain n-3 PUFA intake. Some associations between fatty acids and breast cancer varied by age and tumor phenotype defined by hormone receptor status. Increased intake of fish and other foods rich in long-chain n-3 PUFAs and reduced n-6 PUFA intake might reduce breast cancer risk.
Collapse
Affiliation(s)
- Julie K Bassett
- Cancer Epidemiology Centre, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.
| | - Allison M Hodge
- Cancer Epidemiology Centre, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia
| | - Dallas R English
- Cancer Epidemiology Centre, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, 3010, Australia
| | - Robert J MacInnis
- Cancer Epidemiology Centre, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, 3010, Australia
| | - Graham G Giles
- Cancer Epidemiology Centre, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, 3010, Australia.,Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia
| |
Collapse
|
33
|
Differences in breast cancer characteristics and outcomes between Caucasian and Chinese women in the US. Oncotarget 2016; 6:12774-82. [PMID: 25904050 PMCID: PMC4494973 DOI: 10.18632/oncotarget.3666] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Accepted: 02/28/2015] [Indexed: 12/21/2022] Open
Abstract
Chinese breast cancer patients living in the United States (US) can experience different disease patterns than Caucasians, which might allow for predicting the future epidemiology of breast cancer in China. We aimed to compare the clinicopathologic characteristics and outcomes of Caucasian and Chinese female breast cancer patients residing in the US. The study cohort consisted of 3868 Chinese and 208621 Caucasian women (diagnosed from 1990 to 2009) in the US Surveillance, Epidemiology, and End Results (SEER) database. Compared with the Caucasian patients, the US-residing Chinese patients had a younger age at diagnosis and a higher family income, remained married longer, and more frequently lived in metropolitan areas. Other tumor characteristics were similarly distributed between the two races. Compared with the Caucasians, the Chinese patients had a significantly improved overall survival (OS) but similar breast cancer-specific survival (BCSS). Our analysis suggested that US-residing Chinese patients had significant differences in age, family income, marital status and area of residence, compared with their Caucasian counterparts. No significant disparities were noted in BCSS between the two races, whereas the Chinese patients had a significantly better OS. These findings warrant further investigation and should be considered in the screening and treatment of breast cancer.
Collapse
|
34
|
Cao Y, Hou L, Wang W. Dietary total fat and fatty acids intake, serum fatty acids and risk of breast cancer: A meta-analysis of prospective cohort studies. Int J Cancer 2015; 138:1894-904. [PMID: 26595162 DOI: 10.1002/ijc.29938] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2015] [Revised: 10/25/2015] [Accepted: 11/18/2015] [Indexed: 01/01/2023]
Abstract
Results from prospective cohort studies on the association between dietary total fat and fatty acids intake and risk of breast cancer remain controversial. Pertinent prospective cohort studies were identified by a search of Embase and PubMed from inception to September 2015. Study-specific relative risks (RRs) with 95% confidence intervals were pooled using a random-effect model. Between-study heterogeneity and publication bias were assessed, and sensitivity analysis was conducted. Twenty-four independent studies on dietary total fat and fatty acids intake and seven studies on serum fatty acids were included. The pooled RR of breast cancer for the highest vs. lowest category of dietary total fat intake was 1.10 (1.02-1.19); however, no association was observed in studies adjusting for traditional risk factors of breast cancer. No association was observed between animal fat, vegetable fat, saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), n-3 PUFA, n-6 PUFA, eicosapentaenoic acid, docosahexaenoic acid, alpha-linolenic acid, oleic acid, linoleic acid and arachidonic acid and risk of breast cancer. The pooled RRs of breast cancer for the highest vs. lowest category of serum SFA, MUFA, PUFA, n-3 PUFA and n-6 PUFA were 1.00 (0.78-1.28), 1.41 (0.99-2.03), 0.59 (0.27-1.30), 0.81 (0.60-1.10) and 0.84 (0.60-1.18), respectively. Results from this meta-analysis suggested that dietary total fat and fatty acids might be not associated with risk of breast cancer.
Collapse
Affiliation(s)
- Yi Cao
- Department of Biochemistry, Qingdao University Medical College, Qingdao, China
| | - Lin Hou
- Department of Biochemistry, Qingdao University Medical College, Qingdao, China
| | - Weijing Wang
- Department of Epidemiology and Health Statistics, Qingdao University Medical College, Qingdao, China
| |
Collapse
|
35
|
Abstract
Meat is a food rich in protein, minerals such as iron and zinc as well as a variety of vitamins, in particular B vitamins. However, the content of cholesterol and saturated fat is higher than in some other food groups. Processed meat is defined as products usually made of red meat that are cured, salted or smoked (e.g. ham or bacon) in order to improve the durability of the food and/or to improve colour and taste, and often contain a high amount of minced fatty tissue (e.g. sausages). Hence, high consumption of processed foods may lead to an increased intake of saturated fats, cholesterol, salt, nitrite, haem iron, polycyclic aromatic hydrocarbons, and, depending upon the chosen food preparation method, also heterocyclic amines. Several large cohort studies have shown that a high consumption of processed (red) meat is related to increased overall and cause-specific mortality. A meta-analysis of nine cohort studies observed a higher mortality among high consumers of processed red meat (relative risk (RR) = 1·23; 95 % CI 1·17, 1·28, top v. bottom consumption category), but not unprocessed red meat (RR = 1·10; 95 % CI 0·98, 1·22). Similar associations were reported in a second meta-analysis. All studies argue that plausible mechanisms are available linking processed meat consumption and risk of chronic diseases such as CVD, diabetes mellitus or some types of cancer. However, the results of meta-analyses do show some degree of heterogeneity between studies, and it has to be taken into account that individuals with low red or processed meat consumption tend to have a healthier lifestyle in general. Hence, substantial residual confounding cannot be excluded. Information from other types of studies in man is needed to support a causal role of processed meat in the aetiology of chronic diseases, e.g. studies using the Mendelian randomisation approach.
Collapse
|
36
|
Potentas E, Witkowska AM, Zujko ME. Mediterranean diet for breast cancer prevention and treatment in postmenopausal women. PRZEGLAD MENOPAUZALNY = MENOPAUSE REVIEW 2015; 14:247-53. [PMID: 26848297 PMCID: PMC4733898 DOI: 10.5114/pm.2015.56381] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/14/2015] [Accepted: 10/27/2015] [Indexed: 01/11/2023]
Abstract
Breast cancer has become a big oncological concern both in Poland and most countries around the world. Epidemiological studies show that women who are directly in danger of suffering from breast cancer are mainly postmenopausal women. Due to the seriousness of the problem more attention is devoted to preventative measures that should be undertaken. That is why, Mediterranean diet and its beneficial effects on health started to be discussed. This diet contains antioxidants and shows anti-inflammatory properties which are crucial in breast cancer prevention. Its components are fish, olive oil, unrefined cereals, herbs, fruits and vegetables. In 1960s there was research done on the influence of low fat diet, as a preventative measure, on coronary artery disease. In 1980s, an interest in this diet grew and there was a great come-back to the origins of the diet. It led to estimation of its influence on cardiological and cancer diseases. Many positive effects were observed among people living in the Mediterranean area as far as health qualities of the diet are concerned. Mediterranean diet was compared with high fat diet of people living in Northern Europe and the USA. It seems to create new dietary recommendations as a preventative measure in breast cancer disease. The following article presents most recent data on the importance of Mediterranean diet as a prevention against breast cancer.
Collapse
Affiliation(s)
- Elżbieta Potentas
- Department of Food Commodities Science and Technology, Medical University of Białystok, Poland
| | - Anna Maria Witkowska
- Department of Food Commodities Science and Technology, Medical University of Białystok, Poland
| | | |
Collapse
|
37
|
Abstract
The associations between saturated fatty acid (SFA) consumption and risk of breast cancer (BC) remains inconclusive. Therefore, we conducted this meta-analysis to determine the quantitative relations between dietary SFA intake and incidence of BC.Literatures published up to April 2015 were systematically screened through Pubmed and Web of Science. Relevant publication quality was evaluated by conducting the Newcastle-Ottawa scale. We used fixed effects models or random effect models to calculate the summary relative risks (RRs) and odds ratios (ORs), and conducted sensitivity analyses and evaluated the publication bias.We identified a total of 52 studies (24 cohort studies and 28 case-control studies), with over 50,000 females diagnosed with BC. The associations between dietary SFA intake and risk of BC were 1.18 for case-control studies (high vs low intake, 95% confidence interval [CI] = 1.03-1.34) and 1.04 for cohort studies (95% CI = 0.97-1.11). When restricted analyses to population-based studies, positive associations were observed for both cohort (RR [95% CI] = 1.11 [1.01-1.21]) and case-control studies (OR [95% CI] = 1.26 [1.03-1.53]). Additionally, for case-control studies, significant positive associations between higher SFA intake and BC risk were observed for Asian (OR [95% CI] = 1.17 [1.02-1.34]) and Caucasian (OR [95% CI] = 1.19 [1.00-1.41]), as well as for postmenopausal women (OR = 1.33, 95% CI: 1.02-1.73). In contrast, higher dietary SFA intake was not associated with risk of BC among premenopausal women, in cohort studies or hospital-based studies.A positive association between higher dietary SFA intake and postmenopausal BC risk was observed in case-control but not in cohort studies. More studies are warranted to confirm these findings.
Collapse
Affiliation(s)
- Hui Xia
- From the Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing, P.R. China
| | | | | | | |
Collapse
|
38
|
Ahmed S, Shahid R, Episkenew J. Disparity in cancer prevention and screening in aboriginal populations: recommendations for action. Curr Oncol 2015; 22:417-26. [PMID: 26715875 PMCID: PMC4687663 DOI: 10.3747/co.22.2599] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
Historically, cancer has occurred at a lower rate in aboriginal populations; however, it is now dramatically increasing. Unless preventive measures are taken, cancer rates among aboriginal peoples are expected to soon surpass those in non-aboriginal populations. Because a large proportion of malignant disorders are preventable, primary prevention through socioeconomic interventions, environmental changes, and lifestyle modification might provide the best option for reducing the increasing burden of cancers. Such efforts can be further amplified by making use of effective cancer screening programs for early detection of cancers at their most treatable stage. However, compared with non-aboriginal Canadians, many aboriginal Canadians lack equal access to cancer screening and prevention programs. In this paper, we discuss disparities in cancer prevention and screening in aboriginal populations in Canada. We begin with the relevant definitions and a theoretical perspective of disparity in health care in aboriginal populations. A framework of health determinants is proposed to explain the pathways associated with an increased risk of cancer that are potentially avoidable. Major challenges and knowledge gaps in relation to cancer care for aboriginal populations are addressed, and we make recommendations to eliminate disparities in cancer control and prevention.
Collapse
Affiliation(s)
- S. Ahmed
- Department of Medicine, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK
- Department of Oncology, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK
- Department of Community Health and Epidemiology, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK
| | - R.K. Shahid
- Department of Medicine, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK
- Department of Community Health and Epidemiology, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK
| | - J.A. Episkenew
- Indigenous Peoples’ Health Research Centre, University of Regina, Regina, SK
| |
Collapse
|
39
|
Wang F, Yu L, Wang F, Liu L, Guo M, Gao D, Zhang Q, Li Y, Li L, Fu Q, Yu Z. Risk factors for breast cancer in women residing in urban and rural areas of eastern China. J Int Med Res 2015; 43:774-89. [PMID: 26475794 DOI: 10.1177/0300060515592901] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2014] [Accepted: 06/03/2015] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVE To investigate breast cancer risk factors in Chinese women residing in urban and rural areas of eastern China using a large-scale cross-sectional survey. METHODS In this multistage, stratified cluster sampling epidemiological survey, information on demographic characteristics, diet and lifestyle variables were gathered using a carefully designed questionnaire. Multivariate logistic regression analysis and subgroup analyses of the data were performed, including separate analyses of data from women residing in urban and rural areas. RESULTS A total of 122,058 women were included in the survey. Age, body mass index, number of miscarriages, family history of breast cancer and menopausal status were found to be risk factors for breast cancer, while the consumption of soya bean products was a protective factor. Among women residing in urban areas, high or moderate intake of soya bean products and red meat were protective factors. Among women residing in rural areas, obesity and a high intake of milk were identified as risk factors for breast cancer, while a moderate intake of soya bean products was a protective factor. CONCLUSIONS This type of data is crucial for understanding the risk factors for breast cancer and could facilitate the development and targeting of effective intervention strategies, with the ultimate aim of breast cancer prevention.
Collapse
Affiliation(s)
- Feng Wang
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - LiXiang Yu
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - Fei Wang
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - LiYuan Liu
- Epidemiology Institute, School of Public Health, Shandong University, Jinan, Shandong, China
| | - MingMing Guo
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - DeZong Gao
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - Qiang Zhang
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - YuYang Li
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - Liang Li
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - QinYe Fu
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| | - ZhiGang Yu
- Department of Breast Diseases, Second Hospital of Shandong University, Jinan, Shandong, China
| |
Collapse
|
40
|
Inoue-Choi M, Sinha R, Gierach GL, Ward MH. Red and processed meat, nitrite, and heme iron intakes and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer 2015; 138:1609-18. [PMID: 26505173 DOI: 10.1002/ijc.29901] [Citation(s) in RCA: 66] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2015] [Revised: 09/30/2015] [Accepted: 10/16/2015] [Indexed: 12/13/2022]
Abstract
Previous studies have shown inconsistent associations between red and processed meat intake and breast cancer risk. N-nitroso compounds and heme iron have been hypothesized as contributing factors. We followed 193,742 postmenopausal women in the NIH-AARP Diet and Health Study and identified 9,305 incident breast cancers (1995-2006). Dietary intake was assessed using a food frequency questionnaire at baseline. We adjusted daily intakes of meat, nitrite and heme iron for energy intake using the nutrient density method. We estimated multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) by quintiles of dietary exposures for all breast cancer, by stage (in-situ, localized, regional/distant) and by estrogen/progesterone receptor (ER/PR) status using Cox proportional hazards regression. Total red meat intake was positively associated with risk of regional/distant cancer (p-trend = 0.02). The risk was 25% higher in the highest vs. lowest intake quintile (95% CI = 1.03-1.52). Higher processed red meat intake (Q5 vs. Q1) was associated with 27% higher risk of localized breast cancer (95% CI = 1.01-1.27, p-trend = 0.03) and a 19% higher risk of regional/distant cancer (95% CI = 0.98-1.44, p-trend = 0.10). In addition, higher nitrite intake from processed red meat was positively associated with localized cancer (HR for Q5 vs. Q1 = 1.23, 95% CI = 1.09-1.39, p-trend < 0.0001). Heme iron intake was positively associated with breast cancer risk overall and all cancer stages (p-trend = 0.02-0.05). No heterogeneity was observed in risk associations by hormone receptor status. Our findings suggest that high consumption of red meat and processed meat may increase risk of postmenopausal breast cancer. Added nitrite and heme iron may partly contribute to these observed associations.
Collapse
Affiliation(s)
- Maki Inoue-Choi
- Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.,Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD
| | - Rashmi Sinha
- Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
| | - Gretchen L Gierach
- Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
| | - Mary H Ward
- Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
| |
Collapse
|
41
|
Leporq B, Lambert SA, Ronot M, Boucenna I, Colinart P, Cauchy F, Vilgrain V, Paradis V, Van Beers BE. Hepatic fat fraction and visceral adipose tissue fatty acid composition in mice: Quantification with 7.0T MRI. Magn Reson Med 2015; 76:510-8. [PMID: 26527483 DOI: 10.1002/mrm.25895] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2014] [Revised: 07/23/2015] [Accepted: 07/25/2015] [Indexed: 12/21/2022]
Abstract
PURPOSE To develop an MRI method for quantifying hepatic fat content and visceral adipose tissue fatty acid composition in mice on a 7.0T preclinical system. METHODS MR acquisitions were performed with a multiple echo spoiled gradient echo with bipolar readout gradients. After phase correction, the number of double bounds (ndb) and the number of methylene interrupted double bounds (nmidb) were quantified with a model including eight fat components, and parametric maps of saturated, monounsaturated, and polyunsaturated fatty acids were derived. The model included a complex error map to correct for the phase errors and the amplitude modulation caused by the bipolar acquisition. Validations were performed in fat-water emulsions and vegetable oils. In vivo, the feasibility was evaluated in mice receiving a high-fat diet containing primarily saturated fatty acids and a low-fat diet containing primarily unsaturated fatty acids. RESULTS Linear regressions showed strong agreements between ndb and nmidb quantified with MRI and the theoretical values calculated using oil compositions, as well as between the proton density and the fat fractions in the emulsions. At MRI, the mouse liver fat fraction was smaller in mice fed the low-fat diet compared with mice fed the high-fat diet. In visceral adipose tissue, saturated fatty acids were significantly higher, whereas monounsaturated and polyunsaturated fatty acids were significantly lower in mice fed the low-fat diet compared with mice fed the high-fat diet. CONCLUSION It is feasible to simultaneously quantify hepatic fat content and visceral adipose tissue fatty acid composition with 7.0T MRI in mice. Magn Reson Med 76:510-518, 2016. © 2015 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Collapse
Affiliation(s)
- Benjamin Leporq
- Laboratory of Imaging Biomarkers, Center of Research on Inflammation, UMR1149 INSERM-University Paris Diderot, Sorbonne Paris Cité, Paris, France
| | - Simon A Lambert
- Laboratory of Imaging Biomarkers, Center of Research on Inflammation, UMR1149 INSERM-University Paris Diderot, Sorbonne Paris Cité, Paris, France.,BHF Centre of Excellence, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital, London, United Kingdom
| | - Maxime Ronot
- Laboratory of Imaging Biomarkers, Center of Research on Inflammation, UMR1149 INSERM-University Paris Diderot, Sorbonne Paris Cité, Paris, France.,Department of Radiology, Beaujon University Hospital Paris Nord, Clichy, France
| | - Imane Boucenna
- Matière et Systèmes Complexes, UMR 7057 CNRS-University Paris Diderot, Sorbonne Paris Cité, Paris, France
| | - Pierre Colinart
- Matière et Systèmes Complexes, UMR 7057 CNRS-University Paris Diderot, Sorbonne Paris Cité, Paris, France
| | - Francois Cauchy
- Department of HPB and liver transplantation, Beaujon University Hospital Paris Nord, Clichy, France
| | - Valerie Vilgrain
- Laboratory of Imaging Biomarkers, Center of Research on Inflammation, UMR1149 INSERM-University Paris Diderot, Sorbonne Paris Cité, Paris, France.,Department of Radiology, Beaujon University Hospital Paris Nord, Clichy, France
| | - Valerie Paradis
- Department of Pathology, Beaujon University Hospital Paris Nord, Clichy, France
| | - Bernard E Van Beers
- Laboratory of Imaging Biomarkers, Center of Research on Inflammation, UMR1149 INSERM-University Paris Diderot, Sorbonne Paris Cité, Paris, France.,Department of Radiology, Beaujon University Hospital Paris Nord, Clichy, France
| |
Collapse
|
42
|
Toledo E, Salas-Salvadó J, Donat-Vargas C, Buil-Cosiales P, Estruch R, Ros E, Corella D, Fitó M, Hu FB, Arós F, Gómez-Gracia E, Romaguera D, Ortega-Calvo M, Serra-Majem L, Pintó X, Schröder H, Basora J, Sorlí JV, Bulló M, Serra-Mir M, Martínez-González MA. Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial: A Randomized Clinical Trial. JAMA Intern Med 2015; 175:1752-1760. [PMID: 26365989 DOI: 10.1001/jamainternmed.2015.4838] [Citation(s) in RCA: 302] [Impact Index Per Article: 33.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
IMPORTANCE Breast cancer is the leading cause of female cancer burden, and its incidence has increased by more than 20% worldwide since 2008. Some observational studies have suggested that the Mediterranean diet may reduce the risk of breast cancer. OBJECTIVE To evaluate the effect of 2 interventions with Mediterranean diet vs the advice to follow a low-fat diet (control) on breast cancer incidence. DESIGN, SETTING, AND PARTICIPANTS The PREDIMED study is a 1:1:1 randomized, single-blind, controlled field trial conducted at primary health care centers in Spain. From 2003 to 2009, 4282 women aged 60 to 80 years and at high cardiovascular disease risk were recruited after invitation by their primary care physicians. INTERVENTIONS Participants were randomly allocated to a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a control diet (advice to reduce dietary fat). MAIN OUTCOMES AND MEASURES Breast cancer incidence was a prespecified secondary outcome of the trial for women without a prior history of breast cancer (n = 4152). RESULTS After a median follow-up of 4.8 years, we identified 35 confirmed incident cases of breast cancer. Observed rates (per 1000 person-years) were 1.1 for the Mediterranean diet with extra-virgin olive oil group, 1.8 for the Mediterranean diet with nuts group, and 2.9 for the control group. The multivariable-adjusted hazard ratios vs the control group were 0.32 (95% CI, 0.13-0.79) for the Mediterranean diet with extra-virgin olive oil group and 0.59 (95% CI, 0.26-1.35) for the Mediterranean diet with nuts group. In analyses with yearly cumulative updated dietary exposures, the hazard ratio for each additional 5% of calories from extra-virgin olive oil was 0.72 (95% CI, 0.57-0.90). CONCLUSIONS AND RELEVANCE This is the first randomized trial finding an effect of a long-term dietary intervention on breast cancer incidence. Our results suggest a beneficial effect of a Mediterranean diet supplemented with extra-virgin olive oil in the primary prevention of breast cancer. These results come from a secondary analysis of a previous trial and are based on few incident cases and, therefore, need to be confirmed in longer-term and larger studies. TRIAL REGISTRATION ISRCTN.org Identifier: ISRCTN35739639.
Collapse
Affiliation(s)
- Estefanía Toledo
- Department of Preventive Medicine and Public Health, University of Navarra-School of Medicine, Pamplona, Navarra, Spain.,Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain
| | - Jordi Salas-Salvadó
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Human Nutrition Unit, Faculty of Medicine and Health Sciences, Biochemistry Biotechnology Department, Universitat Rovira i Virgili, Reus, Spain
| | - Carolina Donat-Vargas
- Department of Preventive Medicine and Public Health, University of Navarra-School of Medicine, Pamplona, Navarra, Spain.,Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain
| | - Pilar Buil-Cosiales
- Servicio Navarro de Salud-Osasunbidea, Pamplona, Navarra, Spain.,IdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain
| | - Ramón Estruch
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Department of Internal Medicine, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Hospital Clinic, University of Barcelona, Barcelona, Spain
| | - Emilio Ros
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Hospital Clinic, University of Barcelona, Barcelona, Spain
| | - Dolores Corella
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Department of Preventive Medicine, University of Valencia, Valencia, Spain
| | - Montserrat Fitó
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Cardiovascular and Nutrition Research Group, Institut de Recerca Hospital del Mar, Barcelona, Spain
| | - Frank B Hu
- Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts.,Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Fernando Arós
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,University Hospital of Alava, Vitoria, Basque Country, Spain
| | - Enrique Gómez-Gracia
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Department of Preventive Medicine, University of Malaga, Malaga, Spain
| | - Dora Romaguera
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Instituto de Investigación Sanitaria de Palma (IdISPa), Hospital Universitario Son Espases, Palma de Mallorca, Spain
| | - Manuel Ortega-Calvo
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Department of Family Medicine, Primary Care Division of Sevilla, Sevilla, Spain
| | - Lluís Serra-Majem
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Research Institute of Biomedical and Health Sciences, University of Las Palmas de Gran Canaria, Las Palmas, Spain
| | - Xavier Pintó
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge-IDIBELL-UB, Hospitalet de Llobregat, Barcelona, Spain
| | - Helmut Schröder
- Primary Care Division of Barcelona, Institut Català de la Salut and IDiap-Jordi Gol, Barcelona, Spain.,Centro de Investigación Biomédica en Red Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain
| | - Josep Basora
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Human Nutrition Unit, Faculty of Medicine and Health Sciences, Biochemistry Biotechnology Department, Universitat Rovira i Virgili, Reus, Spain
| | - José Vicente Sorlí
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Department of Preventive Medicine, University of Valencia, Valencia, Spain
| | - Mònica Bulló
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Human Nutrition Unit, Faculty of Medicine and Health Sciences, Biochemistry Biotechnology Department, Universitat Rovira i Virgili, Reus, Spain
| | - Merce Serra-Mir
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Hospital Clinic, University of Barcelona, Barcelona, Spain
| | - Miguel A Martínez-González
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain.,IdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain
| |
Collapse
|
43
|
Breast cancer risk factors. MENOPAUSE REVIEW 2015; 14:196-202. [PMID: 26528110 PMCID: PMC4612558 DOI: 10.5114/pm.2015.54346] [Citation(s) in RCA: 116] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 06/13/2015] [Revised: 07/03/2015] [Accepted: 07/16/2015] [Indexed: 12/13/2022]
Abstract
Breast cancer is the most frequently diagnosed neoplastic disease in women around menopause often leading to a significant reduction of these women's ability to function normally in everyday life. The increased breast cancer incidence observed in epidemiological studies in a group of women actively participating in social and professional life implicates the necessity of conducting multidirectional studies in order to identify risk factors associated with the occurrence of this type of neoplasm. Taking the possibility of influencing the neoplastic transformation process in individuals as a criterion, all the risk factors initiating the process can be divided into two groups. The first group would include inherent factors such as age, sex, race, genetic makeup promoting familial occurrence of the neoplastic disease or the occurrence of benign proliferative lesions of the mammary gland. They all constitute independent parameters and do not undergo simple modification in the course of an individual's life. The second group would include extrinsic factors conditioned by lifestyle, diet or long-term medical intervention such as using oral hormonal contraceptives or hormonal replacement therapy and their influence on the neoplastic process may be modified to a certain degree. Identification of modifiable factors may contribute to development of prevention strategies decreasing breast cancer incidence.
Collapse
|
44
|
Han J, Jiang Y, Liu X, Meng Q, Xi Q, Zhuang Q, Han Y, Gao Y, Ding Q, Wu G. Dietary Fat Intake and Risk of Gastric Cancer: A Meta-Analysis of Observational Studies. PLoS One 2015; 10:e0138580. [PMID: 26402223 PMCID: PMC4581710 DOI: 10.1371/journal.pone.0138580] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2015] [Accepted: 09/01/2015] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND AND OBJECTIVES Consumption of dietary fat has been reported to be associated with gastric cancer risk, but the results of epidemiologic studies remain inconsistent. We conducted a meta-analysis to summarize the evidence regarding the association between dietary fat intake and gastric cancer risk. METHODS A comprehensive search of PubMed and EMBASE was performed to identify observational studies providing quantitative estimates between dietary fat and gastric cancer risk. Random effects model was used to calculate the summary relative risk(SRR) in the highest versus lowest analysis. Categorical dose-response analysis was conducted to quantify the association between dietary fat intake and gastric cancer risk. Heterogeneity among studies was evaluated using I2 and tau2(between study variance)statistics. Subgroup analysis and publication bias analysis were also performed. RESULTS Twenty-two articles were included in the meta-analysis. The SRR for gastric cancer was 1.18 for individuals with highest intake versus lowest intake of total fat (95% confidence interval [CI]: 0.999-1.39; n = 28; P< 0.001; tau2 = 0.12; I2 = 69.5%, 95% CI: 55%-79%) and 1.08 with a daily increase in total fat intake (20 g/d) (95%CI: 1.02-1.14; n = 6; P = 0.09; tau2 = 0.002; I2 = 46.8%, 95% CI: 0%-79%). Positive association between saturated fat intake (SRR = 1.31; 95%CI: 1.09-1.58;n = 18;P<0.001; tau2 = 0.08; I2 = 60.6%, 95% CI: 34%-76%), inverse association between polyunsaturated fat intake (SRR = 0.77; 95%CI: 0.65-0.92; n = 16; P = 0.003; tau2 = 0.06; I2 = 56.2%, 95% CI: 23%-75%) and vegetable fat intake (SRR = 0.55; 95%CI: 0.41-0.74; n = 4;P = 0.12; tau2 = 0.04; I2 = 48.6%, 95% CI: 0%-83%), and no association between monounsaturated fat intake (SRR = 1.00; 95%CI: 0.79-1.25; n = 14; P< 0.001; tau2 = 0.10; I2 = 63.0%, 95% CI: 34%-79%) and animal fat intake (SRR = 1.10; 95%CI: 0.90-1.33; n = 6; P = 0.13;tau2 = 0.02; I2 = 42.0%, 95% CI: 0%-70%) and gastric cancer risk were observed. CONCLUSIONS Our results suggest that intake of total fat is potentially positively associated with gastric cancer risk, and specific subtypes of fats account for different effects. However, these findings should be confirmed by further well-designed cohort studies with detailed dietary assessments and strict control of confounders.
Collapse
Affiliation(s)
- Jun Han
- The Clinical Nutrition Center of Shanghai, Department of General Surgery, Zhongshan Hospital of Fudan University, Shanghai, China
| | - Yi Jiang
- The Clinical Nutrition Center of Shanghai, Department of General Surgery, Zhongshan Hospital of Fudan University, Shanghai, China
| | - Xiao Liu
- Nursing Department, Nanjing Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu Province, China
| | - Qingyang Meng
- The Clinical Nutrition Center of Shanghai, Department of General Surgery, Zhongshan Hospital of Fudan University, Shanghai, China
| | - Qiulei Xi
- The Clinical Nutrition Center of Shanghai, Department of General Surgery, Zhongshan Hospital of Fudan University, Shanghai, China
| | - Qiulin Zhuang
- The Clinical Nutrition Center of Shanghai, Department of General Surgery, Zhongshan Hospital of Fudan University, Shanghai, China
| | - Yusong Han
- The Clinical Nutrition Center of Shanghai, Department of General Surgery, Zhongshan Hospital of Fudan University, Shanghai, China
| | - Ying Gao
- Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China
| | - Qiurong Ding
- Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China
| | - Guohao Wu
- The Clinical Nutrition Center of Shanghai, Department of General Surgery, Zhongshan Hospital of Fudan University, Shanghai, China
| |
Collapse
|
45
|
Biological and Nutritional Properties of Palm Oil and Palmitic Acid: Effects on Health. Molecules 2015; 20:17339-61. [PMID: 26393565 PMCID: PMC6331788 DOI: 10.3390/molecules200917339] [Citation(s) in RCA: 181] [Impact Index Per Article: 20.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Revised: 09/02/2015] [Accepted: 09/09/2015] [Indexed: 12/13/2022] Open
Abstract
A growing body of evidence highlights the close association between nutrition and human health. Fat is an essential macronutrient, and vegetable oils, such as palm oil, are widely used in the food industry and highly represented in the human diet. Palmitic acid, a saturated fatty acid, is the principal constituent of refined palm oil. In the last few decades, controversial studies have reported potential unhealthy effects of palm oil due to the high palmitic acid content. In this review we provide a concise and comprehensive update on the functional role of palm oil and palmitic acid in the development of obesity, type 2 diabetes mellitus, cardiovascular diseases and cancer. The atherogenic potential of palmitic acid and its stereospecific position in triacylglycerols are also discussed.
Collapse
|
46
|
Mazzarella L. Why does obesity promote cancer? Epidemiology, biology, and open questions. Ecancermedicalscience 2015; 9:554. [PMID: 26284118 PMCID: PMC4531127 DOI: 10.3332/ecancer.2015.554] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2015] [Indexed: 12/14/2022] Open
Abstract
The association between obesity and/or metabolic syndrome and an elevated mortality from cancer has been confirmed by an astonishing number of studies across nations and ethnicities, such that obesity is now recognised to be among the most prominent cancer risk factors worldwide. Despite this overwhelming evidence and the societal impact of obesity, we know surprisingly little about the underlying molecular mechanisms. This knowledge gap is a major obstacle to the implementation of effective lifestyle change policies. As the scientific community is insecure on what messages it should deliver, administrators are uncertain as to what exactly to recommend, and consumers are confused about whom to believe. This leaves the field flooded with pseudo-scientific recommendations that are hard to eradicate. In this review, I will provide a summary of the existing epidemiological and mechanistic evidence on the relationship between systemic metabolism and cancer, highlighting debated issues and ongoing investigations.
Collapse
Affiliation(s)
- Luca Mazzarella
- European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy
| |
Collapse
|
47
|
Xin Y, Li XY, Sun SR, Wang LX, Huang T. Vegetable Oil Intake and Breast Cancer Risk: a Meta-analysis. Asian Pac J Cancer Prev 2015; 16:5125-35. [DOI: 10.7314/apjcp.2015.16.12.5125] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
48
|
Potter JD. Nutritional epidemiology--there's life in the old dog yet! Cancer Epidemiol Biomarkers Prev 2014; 24:323-30. [PMID: 25515549 DOI: 10.1158/1055-9965.epi-14-1327] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Consideration is given to the idea that the nutritional epidemiology of cancer is dead, as some in the media have claimed. The basis for the claim does not lie in science nor has anyone with relevant knowledge made such a statement-although that, too, has been claimed. Evidence is adduced for the importance of past achievements of nutritional epidemiology. Attention is similarly drawn to recent contributions. In particular, I note the state of play of cancer and plant foods, fat and breast cancer, meat and cancer, vegetarians, intervention studies, migrant studies, and westernization of diet and lifestyle. Some next steps and some currently important questions are outlined.
Collapse
Affiliation(s)
- John D Potter
- Centre for Public Health Research, Massey University, Wellington, New Zealand. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
| |
Collapse
|
49
|
Pot GK, Stephen AM, Dahm CC, Key TJ, Cairns BJ, Burley VJ, Cade JE, Greenwood DC, Keogh RH, Bhaniani A, McTaggart A, Lentjes MAH, Mishra G, Brunner EJ, Khaw KT. Dietary patterns derived with multiple methods from food diaries and breast cancer risk in the UK Dietary Cohort Consortium. Eur J Clin Nutr 2014; 68:1353-8. [PMID: 25052230 PMCID: PMC4340564 DOI: 10.1038/ejcn.2014.135] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2013] [Revised: 05/07/2014] [Accepted: 06/05/2014] [Indexed: 11/09/2022]
Abstract
BACKGROUND/OBJECTIVES In spite of several studies relating dietary patterns to breast cancer risk, evidence so far remains inconsistent. This study aimed to investigate associations of dietary patterns derived with three different methods with breast cancer risk. SUBJECTS/METHODS The Mediterranean Diet Score (MDS), principal components analyses (PCA) and reduced rank regression (RRR) were used to derive dietary patterns in a case-control study of 610 breast cancer cases and 1891 matched controls within four UK cohort studies. Dietary intakes were collected prospectively using 4- to 7-day food diaries and resulting food consumption data were grouped into 42 food groups. Conditional logistic regression models were used to estimate odds ratios (ORs) for associations between pattern scores and breast cancer risk adjusting for relevant covariates. A separate model was fitted for post-menopausal women only. RESULTS The MDS was not associated with breast cancer risk (OR comparing first tertile with third 1.20 (95% CI 0.92; 1.56)), nor the first PCA-derived dietary pattern, explaining 2.7% of variation of diet and characterized by cheese, crisps and savoury snacks, legumes, nuts and seeds (OR 1.18 (95% CI 0.91; 1.53)). The first RRR-derived pattern, a 'high-alcohol' pattern, was associated with a higher risk of breast cancer (OR 1.27; 95% CI 1.00; 1.62), which was most pronounced in post-menopausal women (OR 1.46 (95% CI 1.08; 1.98)). CONCLUSIONS A 'high-alcohol' dietary pattern derived with RRR was associated with an increased breast cancer risk; no evidence of associations of other dietary patterns with breast cancer risk was observed in this study.
Collapse
Affiliation(s)
- Gerda K Pot
- King’s College London, UK
- MRC Human Nutrition Research, Cambridge, UK
| | | | - Christina C Dahm
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus Denmark
| | - Timothy J Key
- Cancer Epidemiology Unit, University of Oxford, Oxford UK
| | | | - Victoria J Burley
- Nutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, UK
| | - Janet E Cade
- Nutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, UK
| | - Darren C Greenwood
- Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, UK
| | - Ruth H Keogh
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK
| | - Amit Bhaniani
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
| | - Alison McTaggart
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
| | - Marleen AH Lentjes
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
| | - Gita Mishra
- MRC Unit for Lifelong Health and Ageing, London, UK
| | - Eric J Brunner
- Department of Epidemiology and Public Health, University College London, UK
| | - Kay Tee Khaw
- Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
| |
Collapse
|
50
|
Zhao Y, Tan YS, Aupperlee MD, Langohr IM, Kirk EL, Troester MA, Schwartz RC, Haslam SZ. Pubertal high fat diet: effects on mammary cancer development. Breast Cancer Res 2014; 15:R100. [PMID: 24156623 PMCID: PMC3978633 DOI: 10.1186/bcr3561] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2013] [Accepted: 10/11/2013] [Indexed: 02/08/2023] Open
Abstract
INTRODUCTION Epidemiological studies linking dietary fat intake and obesity to breast cancer risk have produced inconsistent results. This may be due to the difficulty of dissociating fat intake from obesity, and/or the lack of defined periods of exposure in these studies. The pubertal mammary gland is highly sensitive to cancer-causing agents. We assessed how high fat diet (HFD) affects inflammation, proliferative, and developmental events in the pubertal gland, since dysregulation of these can promote mammary tumorigenesis. To test the effect of HFD initiated during puberty on tumorigenesis, we utilized BALB/c mice, for which HFD neither induces obesity nor metabolic syndrome, allowing dissociation of HFD effects from other conditions associated with HFD. METHODS Pubertal BALB/c mice were fed a low fat diet (12% kcal fat) or a HFD (60% kcal fat), and subjected to carcinogen 7,12-dimethylbenz[a]anthracene (DMBA)-induced tumorigenesis. RESULTS HFD elevated mammary gland expression of inflammatory and growth factor genes at 3 and 4 weeks of diet. Receptor activator of nuclear factor kappa-B ligand (RANKL), robustly induced at 4 weeks, has direct mitogenic activity in mammary epithelial cells and, as a potent inducer of NF-κB activity, may induce inflammatory genes. Three weeks of HFD induced a transient influx of eosinophils into the mammary gland, consistent with elevated inflammatory factors. At 10 weeks, prior to the appearance of palpable tumors, there were increased numbers of abnormal mammary epithelial lesions, enhanced cellular proliferation, increased growth factors, chemokines associated with immune-suppressive regulatory T cells, increased vascularization, and elevated M2 macrophages. HFD dramatically reduced tumor latency. Early developing tumors were more proliferative and were associated with increased levels of tumor-related growth factors, including increased plasma levels of HGF in tumor-bearing animals. Early HFD tumors also had increased vascularization, and more intra-tumor and stromal M2 macrophages. CONCLUSIONS Taken together in this non-obesogenic context, HFD promotion of inflammatory processes, as well as local and systemically increased growth factor expression, are likely responsible for the enhanced tumorigenesis. It is noteworthy that although DMBA mutagenesis is virtually random in its targeting of genes in tumorigenesis, the short latency tumors arising in animals on HFD showed a unique gene expression profile, highlighting the potent overarching influence of HFD.
Collapse
|